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Abstract 
The transcription factor hand1 is expressed in the heart, lateral plate mesoderm (LPM) and 
neural crest cells during development. As Hand1-null mice die early in embryogenesis, 
identification of the precise role of Hand1 in development is difficult. In Xenopus, we observed 
that hand1 expression patterns correlates very closely with development of LPM derivatives, 
leading us to hypothesize that hand1 is required for normal LPM development. Using hand1 
knockdown and overexpression models in Xenopus, development of LPM derivatives were 
assessed by whole mount in situ hybridization. I found that hand1 is required for proper heart 
morphogenesis. Furthermore, hand1 is required for the formation of a complex vasculature 
plexus within embryos, by maintaining early endothelial cell populations however Hand1 is 
not sufficient to induce endothelial cell differentiation. These findings confirm a conserved 
role of Hand1 in heart morphogenesis and suggest a new role for hand1 in development of the 
vasculature plexus.  
 
Keywords: Hand1, Xenopus, lateral plate mesoderm, vascular development, heart 
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Chapter 1: Introduction  
1.1 Early Embryogenesis  
1.1.1 Development of the Germ Layers  
Embryogenesis is defined as the formation and development of an embryo. Gastrulation is a 
critical event in that process and marks the first morphogenetic event following fertilization. 
During gastrulation, the three germ layers of the embryo- the endoderm, mesoderm and 
ectoderm- become clearly segregated. The formation of the three germ layers outlines the basic 
body plan where each germ layer will give rise to specific tissues and organs of the organism 
(Dale and Slack, 1987a).  
Amphibians have been crucial in establishing key molecular events during germ layer 
induction (Kiecker et al., 2016). In particular, Xenopus laevis is a widely used model for 
studying early embryogenesis due to some key features: in vitro fertilization and development, 
which allows for direct observation and manipulation of early embryos; large number of eggs 
per fertilization (a female can produce around 2000 eggs/day); lack of extra-embryonic germ 
layers, allowing for direct gene analysis in the embryo proper and extensive knowledge of early 
development including established fate maps (Blitz et al., 2006; Cao, 2015). Furthermore, 
Xenopus do not require a functional cardiovascular system until late tadpole stages, making 
them an ideal model to study abnormal cardiovascular phenotypes, as these same studies would 
otherwise be lethal in mouse models (Blitz et al., 2006; Levine et al., 2003). Additionally, the 
external development of the embryo and the transparency of the tadpole make visualizing and 
imaging the heart very accessible (Blitz et al., 2006).  
In Xenopus, the ectoderm, the outer germ layer, forms in the animal region of the pre-
gastrulation embryo, the mesoderm forms from the middle region and the endoderm forms in 
the yolky, vegetal region (Cao, 2015). Although the morphogenetic movements of gastrulation 
occur differently in mammals because of the presence of extra-embryonic tissues and 
topological differences, the molecular factors that specify the germ layers are conserved 
(Kiecker et al., 2016). Nieuwkoop (1969) demonstrated that when explants from either the 
animal or vegetal pole of a blastula stage embryo were isolated and cultured, only ectodermal 
(animal) or endodermal (vegetal) tissues were derived. However, when the explants from the 
animal and vegetal pole were combined, mesodermal tissues were then formed from the 
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ectodermal explant, indicating that mesodermal tissues depend on an inductive event to form 
within the embryo (Dale and Slack, 1987a; Nieuwkoop, 1969). The induction of mesoderm 
from ectodermal tissues was further shown to require signals that emanate from the vegetal 
half of the embryo (Nieuwkoop, 1969; Sud, 1971).  
1.1.2 Mesoderm specification  
There have been many studies done to identify the signals required for mesodermal induction 
within the embryo. The signals that emanate from the vegetal half of the embryo to initially 
induce the mesoderm to form were determined to be from maternally derived mRNA, as 
mesoderm induction takes place very early, before new transcription occurs (Woodland and 
Jones, 1987). In addition to the animal-vegetal axis that helps drive endodermal and ectodermal 
fates, there is a dorsal-ventral axis that arises during gastrulation. It was discovered that when 
the most dorsal lip of the embryo was transplanted onto the ventral side of a host embryo, the 
transplanted tissue induced dorsal tissues to form in the surrounding ventral tissue (De 
Robertis, 2009; Harland and Gerhart, 1997).  
Because the ability to induce and organize a second axis was discovered by Hans Spemann, 
leading to the 1935 Nobel Prize , the dorsal region of the mesoderm was termed the Spemann’s 
organizer (Harland and Gerhart, 1997). The remainder of the mesoderm is termed the ventral 
mesoderm (Harland and Gerhart, 1997). The organizer is formed prior to gastrulation, and acts 
during gastrulation to organize embryonic development, primarily by secreting signals to 
differentiate surrounding cells into certain tissue types (Harland and Gerhart, 1997). Although 
the Spemann organizer is located in the dorsal mesoderm, it is responsible for patterning over 
half of the embryo. Numerous signaling molecules involved in specifying the animal-vegetal 
axis and the Spemann organizer have been identified including activin, FGF, BMP-4, wnt and 
Noggin (Smith, 1995). Altering these signaling pathways and gradients during embryogenesis 
demonstrates the importance of these factors, as loss of their activities disrupts normal body 
axis and positioning (Smith, 1995).   
Prior to gastrulation, fate map studies using Xenopus have shown that morphogenetic fields 
are determined quite early in development (Dale and Slack, 1987b; De Robertis, 2009). A fate 
map showing mesodermal fates of a pre-gastrulation embryo is shown in Figure 1.  
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Figure 1. Fate map of Xenopus embryo.  
The lateral plate mesoderm (LPM) is induced to form in the middle of the embryo as seen in 
red. The mesoderm bordering the animal side of the embryo is fated to become the somites. 
The dorsal mesoderm is fated to become pharyngeal endoderm and head mesoderm, while 
the region ventral to that is fated to become the heart and blood islands. The remainder of the 
mesoderm bordering the vegetal side is fated to become to LPM.  
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The most dorsal lip of the mesoderm forms the notochord, head mesoderm and pharyngeal 
endoderm fields, the ventral mesoderm located closest to the animal side constitutes the somite 
field, and the remainder of the ventral mesoderm on the vegetal side constitutes the lateral plate 
mesoderm (LPM) field of the embryo, with the most dorsal area of that field comprising the 
heart field of the embryo. Although it should be noted that a fate map alone does not give 
information regarding the specification or commitment of a particular lineage, but rather the 
potential of each region to give rise to a particular organ or tissue within the embryo (Dale et 
al., 1985). 
The Spemann organizer is also the area of the embryo where the movements of gastrulation 
begin. During gastrulation, the mesoderm as well as the endoderm invaginate through the 
blastopore and line the interior of the embryo. The ectoderm surrounds the most outer layer of 
the embryo, where the mesoderm forms the second layer of the embryo. The cells located at 
the uppermost portion of the mesoderm will give rise the somites and notochord, while the 
mesoderm surrounding the remainder of the embryo will form the LPM as seen in Figure 2.  
1.2 Lateral Plate Mesoderm 
Shortly after gastrulation, once the LPM has formed around the middle of the embryo, the LPM 
splits into two layers during neurulation: the splanchnic layer and the somatic layer, with the 
space between forming the coelom, as seen in Figure 2. The somatic layer of the LPM will 
eventually line the body cavity, whereas the splanchnic layer gives rise to the circulatory 
system, including the heart, blood and vasculature system.  
1.2.1 Patterning within the LPM  
Although the mechanisms surrounding initial mesoderm induction have been highly studied, 
the molecular basis for the regional patterning within the LPM, specifically in the ventrolateral 
mesoderm have not been as extensively studied (Deimling and Drysdale, 2009, 2011; Saint-
Jeannet et al., 1992). However, studies have shown that the underlying endoderm requires 
signals from the mesoderm for proper regional specification and differentiation (Horb and 
Slack, 2001; Rawdon, 2001; Wells and Melton, 2000), suggesting that the LPM has an intrinsic 
pattern of its own.  
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Figure 2. Development of the LPM. 
After gastrulation (stage 14), the LPM forms a layer surrounding the outer layer of the embryo. 
The LPM is then splits into two layers during neurulation (stage 20), the splanchnic mesoderm 
and the somatic mesoderm. The splanchnic mesoderm gives rise to the circulatory system while 
the somatic mesoderm gives rise to the body wall. The space between the layers is termed the 
coelom and forms the body cavity later in development.  
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Traditionally the LPM was considered quite uniform, outside of the two described domains of 
the heart field located at the anterior lateral mesoderm, and both the anterior and posterior 
blood islands located on the ventral side of the embryo (Deimling and Drysdale, 2009). 
However, our lab has previously identified four distinct domains based on expression of 
specific genes along the anterior-posterior axis of the LPM. The marker genes nkx2.5, foxf1, 
hand1 and sall3 are first expressed after neurulation demonstrating that patterning of the LPM 
occurs earlier than previously thought (Deimling and Drysdale, 2009). It is noted that these 
domains are not fully distinct from one another, as some overlap exists at the borders of the 
domains (Deimling and Drysdale, 2009, 2011). 
The locations of each of the four expression domains are shown in Figure 3. The primary heart 
field, which is located in the ventral-anterior mesoderm (Sater and Jacobson, 1989) is marked 
by the expression of nkx2.5, a transcription factor known to be vital for the development of the 
heart (George et al., 2015; Jamali et al., 2001; Zhang et al., 2014). The expression of nkx2.5 
first appears  broadly the in anterior-ventral region during neurulation, and later becomes 
restricted to the heart where it is maintained throughout development (Cleaver et al., 1996; 
Tonissen et al., 1994). Moving posteriorly from the nxk2.5 domain is the foxf1 domain, which 
is localized in the anterior region of the embryo. Foxf1 expression appears first during 
neurulation, initially having a restricted expression domain in the ventral-anterior LPM, 
however throughout development the expression of foxf1 expands posteriorly along the LPM 
(Deimling and Drysdale, 2009; El-Hodiri et al., 2001; Koster et al., 1999). Hand1 is expressed 
posteriorly to that of foxf1 and expression begins during neurulation, forming a saddle shape 
around the middle of the LPM (Deimling and Drysdale, 2009; Sparrow et al., 1998).  Hand1 
expression domains become more defined and constricted throughout development, although 
expression in these regions remains high (Deimling and Drysdale, 2009; Sparrow et al., 1998). 
Finally, the most posterior domain of the LPM is marked by sall3, which is first expressed 
during neurulation (Hollemann et al., 1996). Sall3 expression is located in the LPM posterior 
to that of hand1, however, expression is transient and rapidly declines shortly after neural tube 
closure (Deimling and Drysdale, 2009).  
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Figure 3. Distinct domains within the LPM. 
An in situ hybridization of a stage 20 embryo probed for hand1 expression, where it is located 
in the middle of the LPM. The remaining domains of the LPM are displayed. The primary heart 
field is marked by the expression of nkx2.5 and is located at the anterior-ventral region of the 
embryo. The foxf1 domain is located posterior of that the nkx2.5 expression domain. Finally, 
the sall3 domain is located at the posterior end of the embryo.  
 
 
 
 
 
 
 
 
sall3
hand1
nkx2.5
foxf1
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Using these four  distinct domains as described, our lab was able to demonstrate that anterior-
posterior patterning within the LPM is regulated by fibroblast growth factor (FGF) and retinoic 
acid (RA), because there are shifts in the four domains when either FGF or RA signaling 
pathways were disrupted (Deimling and Drysdale, 2009, 2011). Most importantly, when the 
domains were transiently manipulated using embryonic treatments during neurulation, the 
initial changes in the four expression domains persisted after the treatment was removed, and 
were associated with later developmental defects, such as disrupted heart morphogenesis when 
nkx2.5 domain was lost, and a corresponding shift in the location of the developing vascular 
plexus within the ventral region of the embryo (Deimling and Drysdale, 2009, 2011). Thus, 
the patterning within the LPM occurs early in development, and is important for normal 
patterning and development of the LPM derivatives. As the focus of this thesis is on the 
development of the LPM, it is imperative to discuss the derivates of the LPM, as these will be 
used to assess the regional patterning of the LPM. 
1.2.2 LPM derivatives  
As previously described (Fig. 2) the LPM will split into both the splanchnic layer and somatic 
layer during neurulation, each giving rise to a different subset of tissues. However, the focus 
of this thesis is specifically on the development of the splanchnic mesoderm, which forms the 
circulatory system. The circulatory system is comprised of the heart, vasculature (blood 
vessels) and hematopoietic lineages (blood and myeloid cells), each of which will be discussed 
in further detail.   
1.2.2.1 Early cardiac development  
Cardiac progenitors are first specified during gastrulation (Fig. 4) and these precursor cells are 
located as two bilaterally patches at the most dorsal region of the LPM (Sater and Jacobson, 
1989), which has been determined through fate mapping studies and expression of early cardiac 
transcription factors (Gessert and Kühl, 2009). Although the progenitors of the heart are first 
specified in this region, during gastrulation the heart fields migrate as two bilateral regions and 
relocate in the anterior region of the LPM termed the cardiac crescent. This region is where the 
heart is going to form the functional organ system (Brand, 2003; Mohun et al., 2003). The heart 
tube then begins to form from primary heart field progenitor cells within the cardiac crescent  
(Hempel and Kühl, 2016; Waardenberg et al., 2014).  
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Figure 4. Development of the heart in Xenopus. 
Prior to gastrulation, the cardiogenic fields are specified and located within two bilateral 
patches of the embryo, at stage 10. At stage 20, the cardiac cells are specified within the cardiac 
crescent. Both primary and secondary heart fields are intermingled together and located within 
the same region. By stage 24-28 the primary and secondary heart field have separated. The 
heart tube is thus induced to form in this region and by stage 35 the tube has looped to the 
right. The secondary heart field contributes to the heart during looping. Finally, by stage 46 
the formation of the heart is complete, with chamber formations and atrium and ventricles 
separated. This image was arranged from (Hempel and Kühl, 2016) following Creative 
Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). 
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Once the primary heart tube is formed, the tube undergoes rightwards looping, which is 
accompanied by the elongation of the heart tube through addition of cells from the secondary 
heart field (Dyer and Kirby, 2009; McFadden and Olson, 2002; Mohun et al., 2000). The 
looping of the heart is a critical step during heart morphogenesis, as heart looping determines 
the position and location of the future cardiac chambers (Blitz et al., 2006; McFadden and 
Olson, 2002; Mohun et al., 2000). 
Although there exist differences in heart morphology between Xenopus and mammals, as the 
Xenopus heart only has three chambers (2 atria, 1 ventricle), as opposed to the four chambered 
mammalian heart, the early events leading to heart development and molecular pathways are 
conserved (Mohun et al., 2000; Warkman and Krieg, 2007).  
Nkx2.5 represents one of the first transcription factors that is activated during the specification 
of the heart field (Brand, 2003; Lints et al., 1993). Nkx2.5 is the murine homolog of tinman, 
which was first discovered in Drosophila, where tinman mutants failed to develop a heart, as 
well as the precursors to cardiomyocytes (Bodmer, 1993; Bodmer et al., 1990). Given the 
importance of tinman in fly heart development, the role of nkx2.5 in heart development in other 
species has been studied. Nkx2.5 in mouse and nkx2.5 in Xenopus were found to have the same 
early cardiac expression pattern as tinman, marking the earliest cardiogenic precursors (Lints 
et al., 1993; Newman and Krieg, 1998; Sparrow et al., 2000; Tonissen et al., 1994). 
Unlike in Drosophila, knockout models of nkx2.5 in other species are still able to differentiate 
cardiomyocytes, due to presumed redundancy of other genes involved in cardiac specification, 
such as Gata4/6, Srf, Tbx5 and Tbx20, although the loss of individual genes still has severe 
consequences on heart morphogenesis (Brand, 2003; Haworth et al., 2008; Peterkin et al., 
2005; Tandon et al., 2012; Waardenberg et al., 2014). Knockouts of Nkx2.5 in mice are lethal 
between E9.5-11.5 with defects in heart morphogenesis, failing to form a separation between 
atria and ventricles (Lyons et al., 1995; Yamagishi et al., 2001). In dominant negative nkx2.5 
models in Xenopus, mutant phenotypes exhibited loss of morphologically recognizable cardiac 
tissue, and decreased cardiac marker expression on the injected side of the embryo (Fu et al., 
1998; Grow and Krieg, 1998). Interestingly, over expression of nkx2.5 in Xenopus led to an 
increase in number of differentiating myocardial cells, and thus an increase in overall heart 
size, but function was not compromised (Cleaver et al., 1996). Lack of ectopic myocardial cells 
in Xenopus over expressing nkx2.5 implies that nkx2.5 is not a master regulator of 
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cardiomyocyte differentiation (Cleaver et al., 1996; Grow and Krieg, 1998).  Importantly, 
heterozygous loss of function NKX2.5 mutations in people results in congenital heart defects 
(Kasahara et al., 2000). 
In addition to the role nkx2.5 has during heart morphogenesis, nkx2.5 has recently been shown 
to also be involved in specification of the secondary heart field (George et al., 2015; Guner-
Ataman et al., 2013; Zhang et al., 2014). The secondary heart field represents a group of cells 
that remain proliferative until after the differentiation of the primary heart field, and then 
undergo differentiation later on to contribute to elongation of the heart tube during looping 
morphogenesis (Dyer and Kirby, 2009; Waardenberg et al., 2014). Loss of the secondary heart 
field reduces the population of cardiac cells that contribute to the heart, and thus causes defects 
in heart morphogenesis (Dyer and Kirby, 2009). Isl1 has been shown to mark the cells 
representing the secondary heart field, and loss of isl1 in Xenopus led to phenotypes ranging 
from looping failure and pericardial edema, to a small beating nub where the heart should be 
and thus is required for normal heart development (Brade et al., 2007; Ma et al., 2008). In 
Xenopus, the expression patterns of isl1 and nkx2.5 are similar within the cardiac crescent, but 
represent two distinct populations of progenitors cells within the embryo that are vital for heart 
development (Brade et al., 2007; Dyer and Kirby, 2009; Ma et al., 2008).  
The first terminal differentiation event of cardiomyocytes can be identified by the expression 
of  cardiac troponin I (tnni3) in Xenopus (Drysdale et al., 1994). When expression of tnni3 first 
appears, it is located as two bilateral regions within the heart field at stage 28, and is maintained 
throughout development of the heart (Drysdale et al., 1994).  
Although the complete molecular pathways involved in looping morphogenesis have not been 
eluded, knockouts of either nkx2.5, tbx5, hand1, hand2 and BMP-4 in mice result in looping 
defects suggesting they play a role in looping morphogenesis (Brand, 2003). Defects in looping 
is one of the major causes of congenital heart defects, and thus the molecular events underlying 
this process are of high importance (Blitz et al., 2006; Mohun et al., 2000).   
1.2.2.2 Early vasculature development  
Development of the vascular system begins with the differentiation of mesodermal progenitor 
cells to an endothelial lineage. After initial differentiation, these cells will coalesce to form a 
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primary vascular plexus, which then undergoes remodeling later in development to form the 
final functional vasculature system within the embryo (Marcelo et al., 2013). Vasculature 
development can be separated into two distinct phases: vasculogenesis and angiogenesis 
(Lawson and Weinstein, 2002; Mills et al., 1999; Wilting et al., 1995). Vasculogenesis is 
defined as the de novo formation of endothelial cells from precursor cells (Wilting et al., 1995). 
Angiogenesis occurs when endothelial cells arise from pre-existing endothelial cells, and is 
typically accomplished through sprouting of vessels from a previously formed vessel (Wilting 
et al., 1995).  
The identity of the precursor cell that will give rise to the vasculature is still unclear, although 
the hypothesized cell is typically referred to as a hemangioblast, holding potential to 
differentiate into either a endothelial cell or blood cell lineage (Iraha et al., 2002; Mills et al., 
1999). This support for the idea of a hemangioblast precursors lies with the fact that blood and 
endothelial cells differentiate in such close proximity to each other early in embryo 
development (Iraha et al., 2002; Marcelo et al., 2013; Mills et al., 1999).  
Many of the key signaling molecules required for differentiation toward an endothelial fate 
have been eluded, including FGF-2 and BMP-4 (Iraha et al., 2002; Marcelo et al., 2013).   
The most studied signaling factor during vascular development is vascular endothelial growth 
factor (VEGF) which is required for the growth and migration of endothelial cells, however it 
is noted that VEGF is not sufficient to induce differentiation of precursor cells to an endothelial 
lineage (Liang et al., 2001). VEGF is upregulated in hypoxic areas of developing embryos, and 
serves as the signaling factor to promote vascular growth into those areas of the embryo 
(Wilting et al., 1995).  
Additionally, the transcription factor etv2 is required for differentiation of precursors cells to 
an endothelial fate (Lammerts van Bueren and Black, 2012; Neuhaus et al., 2010; Salanga et 
al., 2010). The requirement of etv2 for vasculature formation has been demonstrated by several 
loss of function studies. Morpholino knockdown of etv2 in zebrafish and Xenopus result in a 
complete loss of vasculature formation (Neuhaus et al., 2010; Sumanas and Lin, 2006). 
Similarly, knockout of Etv2 in mice result in early lethality of embryos exhibiting no evidence 
of blood vessel or blood formation (Lee et al., 2008). Overexpression of etv2 in Xenopus, 
zebrafish and stem cells results in ectopic expression of endothelial markers, thus etv2 is not 
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only required but also sufficient for endothelial cell differentiation (Kataoka et al., 2011; 
Marcelo et al., 2013; Neuhaus et al., 2010; Salanga et al., 2010).  
In Xenopus, etv2 expression begins during neurulation, marking precursor endothelial cells 
(Neuhaus et al., 2010). High levels of etv2 expression are found in developing vascular 
structures and expression is rapidly lost once endothelial cells begin to mature (Marcelo et al., 
2013; Neuhaus et al., 2010).  
Similarly, aplnr, a G-protein coupled receptor is also required for vascular development as 
demonstrated by loss of function models in Xenopus (Cox et al., 2006; Inui et al., 2006). 
Similarly, loss of aplnr in mice is lethal due to both vasculature and cardiac defects (Kang et 
al., 2013). In Xenopus, the expression of aplnr begins after gastrulation and is localized to the 
endothelium layer within endothelial cells, and is similarly downregulated later in development 
(Devic et al., 1996).  
Endothelial cells arise from two distinct locations within the Xenopus embryo (Fig. 5A). One 
population arises at the ventral side of the embryo in close proximity to the ventral blood 
islands, which will form the vitelline vasculature (Cleaver et al., 1997). The second population 
of endothelial cells arise in dorsal region of the embryo where the cardinal veins will develop 
(Cleaver et al., 1997).  
As development continues, the cardinal veins mature and extend to the tail of the embryo, with 
intersomitic vessels beginning to sprout from the cardinal vein. The intersomitic veins are 
considered one of the first forms of angiogenesis within the embryo. Sprouting of the 
intersomitic vessels occurs in a very regulated and controlled manner, such that small 
perturbations in angiogenesis can be observed in these vessels (Helbling et al., 2000; Levine 
et al., 2003). Meanwhile, the vitelline vessels have coalesced and attach to the cardinal veins 
and aortic arches to form a functional vasculature system (Cleaver et al., 1997; Levine et al., 
2003). The locations of these vessels within the embryo are shown in Figure 5B. Blood 
circulation begins through the vasculature system at stage 33 as the heart begins to beat (Levine 
et al., 2003). The expression of ami, a serine protease, is found to correspond to the developing 
vasculature, and is used as a marker for later vasculature development in Xenopus (Inui and 
Asashima, 2006).  
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Figure 5. Vasculature formation in Xenopus embryos. 
An embryo probed with etv2 at stage 25 showcasing the two distinct regions where endothelial 
cells arise (A). The cells arising from the ventral region of the embryo will form the vitelline 
veins while the cells arising from the dorsal region of the embryo will form the posterior 
cardinal vein. Additionally, embryos were probed with the marker ami, to showcase the 
vasculature development at stage 37 (B). The vitelline veins form within the broad region of 
the embryo, with the precursors arising from the ventral region of the embryo and link up to 
the cardinal vein. The cardinal vein runs along the dorsal length of the embryo and arises from 
precursors in the dorsal region of the embryo. The intersomitic vessels arise from sprouting 
angiogenesis coming from the cardinal vein. Embryos are oriented with anterior side to the 
left, posterior side to the right. 
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1.2.2.3 Early hematopoietic development  
There are two distinct blood islands within the Xenopus embryo, the posterior ventral blood 
island (pVBI) and the anterior ventral blood island (aVBI). They both originate from different 
regions of the gastrula, with the pVBI arising from the ventral gastrula mesoderm and the aVBI 
arising from the dorsal gastrula mesoderm. After the movements of gastrulation, they are 
juxtaposed beside each other, with the aVBI located next to the developing heart, and the pVBI 
posteriorly to that of the aVBI as seen in Figure 6 (Costa et al., 2008; Mace et al., 2012). Each 
blood island gives rise to different cell types, with the aVBI giving rise to the myeloid cells of 
the embryo, and the pVBI giving rise to the erythrocytes (red blood cells) of the embryo (Costa 
et al., 2008; Mace et al., 2012). Another distinction between the two blood islands is the timing 
of differentiation, with the aVBI differentiating into myeloid cells during neurulation (stage 
18), while erythrocytes do not differentiate until later in development, around stage 28 (Costa 
et al., 2008; Mace et al., 2012). Thus, the signals involved in differentiation of each lineage 
appear distinct from one another. 
Myeloid cells first appear in Xenopus during neurulation, and expression is initially restricted 
to a small population of cells located posterior to the heart on the ventral side of the embryo 
(Smith et al., 2002). These cells then rapidly proliferate and migrate throughout the embryo 
during early tailbud stages (Smith et al., 2002). These myeloid cells are capable of responding 
to wounds and infections in the embryo, thus the myeloid cells are both differentiated and 
functional a day prior to the differentiation of erythrocytes and formation of a functional 
vasculature system (Costa et al., 2008; Smith et al., 2002). Furthermore it has been shown that 
myeloid cells play a role in normal embryogenesis, through the clearance of apoptotic cells, 
and are also essential for normal heart morphogenesis in Xenopus (Agricola et al., 2016; Smith 
and Mohun, 2011). 
The first gene that is expressed in myeloid precursors cells is spib, an ETS (E-twenty-six) 
transcription factor which is required for both specification and differentiation of myeloid cells 
in Xenopus (Agricola et al., 2016; Costa et al., 2008). Loss of spib in Xenopus results in a loss 
of other early and late myeloid cell markers, however this does not lead to an increase in 
erythrocyte specification in these embryos, thus the separate blood islands are not able to 
compensate for one another (Costa et al., 2008).   
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Figure 6. Locations of the blood islands in Xenopus. 
A ventral view of a stage 21 embryo is shown, depicting of the locations of the aVBI and pVBI 
within the embryo after gastrulation. The aVBI is located near the developing heart of the 
embryo, and will give rise to the myeloid cells, while the pVBI will give rise to erythrocytes.  
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The requirement of spib for myeloid cell development is conserved. In mice, when the DNA 
binding domain of the spib gene is removed, the mice lack the myeloid cell lineages of 
macrophages, neutrophils, and B and T lymphocytes. However the precursors cells for these 
lineages are not abolished (Mckercher et al., 1996; Scott et al., 1994).  
Blood progenitors arise from the pVBI, and contribute to the embryonic blood (Ciau-Uitz et 
al., 2000; Walmsley, 2002). Additionally, adult blood arises from a separate region of the 
embryo, the dorsal lateral plate (DLP) (Ciau-Uitz et al., 2000; Walmsley, 2002). The blood 
cells that arise in the pVBI differentiate prior to the blood cells that arise from the DLP, and 
the pVBI derived blood cells have been shown in Xenopus to be the only blood cells present 
in circulation throughout early development of the embryo (Kau and Turpen, 1983). Lineage 
tracing of the two blood populations demonstrated that each blood compartment arises from 
different regions of the embryo during development, suggesting that each population relies on 
different signals to induce their differentiation (Ciau-Uitz et al., 2000). For example, BMP 
(bone morphogenetic protein) signaling is required for the specification and differentiation of 
embryonic blood lineages, but is dispensable for the differentiation of adult blood lineages 
(Ciau-Uitz et al., 2000; Walmsley, 2002). Loss of BMP-4 signaling in Xenopus lead to a 
decrease in expression of globin, which is a marker of differentiated blood cells, while ectopic 
BMP-4 signaling in dorsal explants of embryos lead to an induction of globin expression in the 
tissue (Iraha et al., 2002; Kumano et al., 1999).  
BMP signaling has also been shown to induce scl (stem cell leukemia) expression (Mead, 
1998). Scl is the first known marker of the blood lineages and expression of scl appears in the 
ventral side of Xenopus embryos just after gastrulation (Iraha et al., 2002; Mead, 1998; Nastos 
et al., 2002). Loss of scl in mice and Xenopus results in disruption of normal hematopoiesis, 
and is thus required in committing cell lineages to a blood cell fate (Mead, 1998; Nastos et al., 
2002).  
Differentiated blood cells are located in the most ventral region of the embryo forming a V-
shape and first appear in late tailbud stages (Zon, 1995). Shortly after the heart begins beating, 
the anterior region of the blood islands begin to enter the heart through the forming primitive 
vasculature, thereby establishing circulation throughout the embryo (Zon, 1995).  
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1.3 Expression pattern of hand1 throughout Xenopus development  
Although hand1 is not a pan lateral plate marker, it occupies majority of the LPM (as seen in 
Figure 3) and has been correlated with vasculature formation, thus the focus of this thesis is on 
the role of hand1 in LPM development. The expression of hand1 first appears in Xenopus at 
stage 14, once gastrulation is completed, with no maternal transcripts of hand1 identifiable in 
unfertilized eggs (Sparrow et al., 1998). The expression of hand1 is localized to the middle of 
the LPM, forming a saddle shape around the embryo (Deimling and Drysdale, 2009). 
Expression of hand1 increases throughout development, reaching peak levels at early tailbud 
stages (Sparrow et al., 1998). As development continues, hand1 expression is maintained in 
the broad region of the embryo, however expression does not extend to the very posterior end. 
The expression of hand1 also appears in the heart, beginning at stage 28, and is maintained 
during heart development, however expression of hand1 decreases to barely detectable levels 
once the embryos reach stage 42 and is undetectable in adult tissues (Sparrow et al., 1998).  
1.4 Hand1 
1.4.1 Hand1 structure and function 
Hand1 (Heart And Neural Derived factor 1) is a Class B bHLH transcription factor, consisting 
of both a DNA binding domain, which is composed of a number of basic amino acids, and a 
second dimerization domain, which consists of an amphipathic a-helix, followed by a loop 
that varies in length and then another a-helix (Firulli et al., 2003). Hand1 was first discovered 
using a yeast two-hybrid system, screening for novel bHLH transcription factors that dimerize 
with the Class A E12 bHLH in mouse (Cserjesi et al., 1995). Originally named eHAND, hand1 
encodes a protein that is 216 amino acids in length, and the genetic code of hand1 has been 
highly conserved throughout evolution (Cserjesi et al., 1995; Firulli, 2003). Hand1 mediates 
its actions by binding to DNA through an E-box sequence as either a homo- or heterodimer to 
regulate gene expression (Firulli, 2003; Firulli et al., 2003). The dimerization that occurs 
between the two bHLH proteins confers a unique combined DNA binding domain that 
recognizes a specific E-box sequence (Firulli, 2003).  
Unlike most Class B bHLH that typically only form dimers with Class A proteins, Hand1 has 
been shown to dimerize with a multitude of different Class A and B bHLH factors (Firulli et 
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al., 2000). Using a mammalian two-hybrid system, it was shown that Hand1 is able to form 
homodimers and heterodimers with Hand2, Mash1, MyoD and the Hairy-related transcription 
factors (Firulli et al., 2000). Furthermore, Hand1 is able to dimerize with the class A bHLH 
proteins, E12 and E47 (Firulli et al., 2000).  
Hand1 has been shown to act as both a transcriptional activator and repressor (Hill and Riley, 
2004). Furthermore, studies have shown that Hand1 can negatively affect the function of other 
bHLH transcription factors through dimerization with them, similar to what is seen with Id 
(inhibitor of DNA) HLH proteins (Firulli et al., 2000; Scott et al., 2000). Hand1 has been 
shown to inhibit MyoD function by forming stable dimers with MyoD and E12 and thereby 
disrupting MyoD DNA binding (Firulli et al., 2000). Additionally, Hand1 can inhibit Mash1 
function by decreasing the pool of binding partners (Scott et al., 2000).  
Post-translational modifications have also been shown to affect the dimerization properties of 
Hand1 by altering the affinity of Hand1 to dimerization partners (Firulli et al., 2003). When 
phosphorylation of Hand1 in mice is disrupted, this led to defects in limb morphogenesis, 
however, complete loss of Hand1 has no effect on limb morphogenesis, suggesting that the 
control of Hand1 binding partners through phosphorylation events is critical for its function 
(Firulli et al., 2017). The unique ability of Hand1 to bind to a variety of partners, and regulation 
of the binding partners through post-translational modifications reveals the complex 
mechanisms in which Hand1 regulates transcription and allows for the various different 
functions of Hand1 within different tissues (Conway et al., 2010; Firulli et al., 2000).  
Although the function of Hand1 has been highly studied, there are still limited insights into the 
direct transcriptional targets of Hand1. Thymosin b4 (Tb4), an actin monomer binding protein, 
has been confirmed as a direct target of Hand1 (Smart et al., 2010). Differential gene 
expression comparisons have identified genes mis-regulated in Hand1 null as compared to 
Hand1 wildtype embryoid bodies, such as fibronectin, cardiac actin, cyclin D2, Wnt2 and 
cystatin C, however it is not known if these are direct targets (Smart et al., 2002). Recently, 
chromatin immunoprecipitation (ChIP) sequencing of Hand1 in primed multipotent 
cardiovascular mesoderm cells identified potential targets of Hand1, such as Pecam, Vwf, 
Sox17, Sox7 and Fli1, although it is unclear if Hand1 functions to activate or repress them (Org 
et al., 2015).  
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1.4.2 Hand1 expression  
Hand1 has been highly conserved throughout evolution, and although the expression pattern 
of hand1 between species is generally consistent there are some interspecies variations in tissue 
specific expression patterns (Firulli, 2003). The expression of hand1 is highly embryonic in all 
species, and is found in low to undetectable levels in adult tissues, expect in disease phenotypes 
(Cserjesi et al., 1995; Firulli, 2003). During development, hand1 is highly expressed in the 
extra-embryonic tissues, lateral mesoderm, the heart and in neural crest derivatives (Cserjesi 
et al., 1995). In mice, although initially expressed throughout the developing heart, Hand1 
becomes restricted to the future left ventricle, however this asymmetrical expression pattern is 
not seen in either chick or Xenopus embryos (Angelo et al., 2000; Cserjesi et al., 1995; 
Srivastava et al., 1995).  
1.4.3 Hand family 
The most closely related transcription factor to hand1 is hand2. Both are closely related to the 
twist family of transcription factors (Conway et al., 2010). Both hand factors are highly 
expressed during embryo development and are found at lower levels in adult tissues (Conway 
et al., 2010). The bHLH domain of hand2 is 90% conserved compared to the bHLH of hand1 
suggesting that they have a similar function, although the remaining identity of hand2 is less 
conserved (Conway et al., 2010; Srivastava et al., 1995).  
Support for functional redundancy between the two hand factors comes from chick 
experiments, where loss of either hand1 or hand2 using antisense oligonucleotides were viable, 
but loss of both hand factors resulted in lethality due to cardiac defects (Liang et al., 2001). 
Interestingly, in zebrafish, there is only a single hand gene, which more closely resembles the 
sequence and expression of hand2, suggesting that hand2 may be the ancestral member of the 
subclass of hand proteins (Angelo et al., 2000; Yelon et al., 2000). The differing expression 
patterns of hand1 and hand2 within the embryo suggests that they have a similar function 
within tissues, with hand2 expressed in the decidium, heart, autonomic nervous system and 
neural crest derivatives (Srivastava et al., 1995). Furthermore, in mice, while both Hand factors 
initially overlap in expression within the heart, upon the beginning of morphogenesis, the 
expression pattern of each factor shifts; Hand1 expression becomes restricted to the future left 
ventricle and Hand2 expression becomes restricted to the future right ventricle (Firulli et al., 
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2000). This differing expression pattern forms a gradient of Hand factors throughout the 
developing heart, where the Hand factors can form heterodimers with each other in the tissues 
where they are co-expressed (Firulli et al., 2000).  
Although initially thought to have redundant functions, knock-in of Hand2 to the Hand1 locus 
in mice was lethal, providing evidence that both Hand factors have a unique and non-redundant 
roles in development (Firulli et al., 2010). Furthermore, Hand2 null mice are lethal beyond 
E10.5 due to defects in heart morphogenesis and disorganized vasculature formation 
(Srivastava et al., 1997; Yamagishi et al., 2000). Thus, both hand genes play important roles 
in development and are unable to fully compensate for one another.  
1.4.4 Hand1 loss of function experiments  
The first loss of function experiments of hand1 were done in chick embryos using antisense 
oligonucleotides targeting hand1 mRNA (Srivastava et al., 1995). The loss of hand1 did not 
have any effect on cardiovascular development. However, when antisense oligonucleotides 
were used targeting both the hand1 and hand2 gene in chick, heart development arrested at the 
looping stage (Srivastava et al., 1995). The embryos died due to hemodynamic insufficiency 
resulting from the failure of the heart valves to form accompanied by heart distention and 
pericardial edema (Srivastava et al., 1995). In contrast, knockout of Hand1 in mice led to early 
lethality of the embryo at E8.5, a timepoint before the heart is required for viability of the 
embryo, suggesting the lethality was due to defects in extra-embryonic tissues (Firulli et al., 
1998; Riley et al., 1998). A tetraploid-aggregation model was then used to rescue the extra-
embryonic defects, however embryos were still not viable beyond E10.5, exhibiting defects in 
heart looping and pericardial edema (Riley et al., 1998). The heart phenotype of the tetraploid-
aggregation model of Hand1-null mice was very similar to the phenotype seen in Nkx2.5-null 
mice, suggesting that Nkx2.5 might function by inducing Hand1, as Hand1 expression is lost 
in Nkx2.5-null mice (Biben and Harvey, 1997; Riley et al., 1998; Thomas et al., 1998).  
Other conditional knockout models of Hand1 have been employed to determine the cause of 
early lethality in Hand1-null mice. Hand1 has been shown to be important in the differentiation 
of the trophoblast cells, suggesting the early lethality of embryos may be due to a defect in this 
lineage, however rescue experiments did not rescue the extra-embryonic or embryonic defects 
observed (Cross et al., 1995; Morikawa and Cserjesi, 2004; Scott et al., 2000). Using a gene 
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replacement strategy, Hand1 was deleted in the yolk sac to examine the role of Hand1 in the 
vasculature development of the extra-embryonic mesoderm (Morikawa and Cserjesi, 2004). 
Loss of Hand1 in the yolk sac lead to vascular defects as well as abnormal folding of the 
endoderm (Morikawa and Cserjesi, 2004). In order to determine the precise cause of early 
lethality of Hand1-null mice, Maska et al. (2010) created a conditional Hand1-null mouse, 
deleting Hand1 in the lateral mesoderm and the extraembryonic mesoderm except the 
trophectoderm. Deletion in both of these lineages still led to early lethality, therefore another 
conditional Hand1-null mice was created to only delete Hand1 in the lateral mesoderm (Maska 
et al., 2010). Of the conditional lateral mesoderm Hand1-null mice, only 2 of 8 survived until 
birth; the phenotypes of surviving embryos ranged in severity, with the most severe phenotype 
exhibiting defects in ventral closure leading to gut hernias, showing a disorganization and 
thinning of the endothelial smooth muscle layer (Maska et al., 2010). Although this model 
confirms that the early lethality of Hand1-null mice is due to defects in the extra-embryonic 
mesoderm, defects were still observed in conditional lateral mesoderm Hand1-null mice 
suggesting Hand1 plays an important role within the lateral mesoderm during development as 
well (Maska et al., 2010).  
To further understand the role Hand1 plays during heart development, Riley et al. (2000) 
created a chimeric knockout of Hand1 in mice and found that when less than 50% of cells lost 
Hand1 there was no observable phenotype of the Hand1 mutants. However, when 60% of cells 
were Hand1-null, the hearts of these chimera embryos resembled Hand1 mutant mice, 
demonstrating that the remaining wild type cells were not sufficient to rescue the defects (Riley 
et al., 2000). Additionally, a heart-specific conditional Hand1 knockout, where cre-
recombinase was driven by an Nkx2.5 enhancer, was created to specifically delete Hand1 
expression in the heart cells (McFadden et al., 2005). These cardiac specific conditional 
Hand1-null mice survived until birth, but only survived for two days postnatally (McFadden 
et al., 2005). Hearts of these mice were observed to have congenital heart defects, including 
septal defects, a double outlet right ventricle and hyperplastic atrioventricular valves 
(McFadden et al., 2005). The limitations of the timing and mosaicism of Cre-driver Nkx2.5 
used have been implied for the difference in phenotype severity compared to the tetraploid 
rescued Hand1-null mice (McFadden et al., 2005), thus the precise role of Hand1 in heart 
development remains incompletely understood.  
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The congenital heart defects observed in conditional Hand1-null mice suggests that defective 
HAND1 could play a role in development of congenital heart defects in humans (McFadden et 
al., 2005). A study looked at genetic mutations in patients with isolated congenital heart defects 
and found a patient with a novel mutation in the HAND1 gene, a heterozygous SNP in the 
bHLH domain (Wang et al., 2017). The SNP resulted in an amino acid substitution at position 
118 from an arginine to a cysteine, altering an evolutionary conserved amino acid (Wang et 
al., 2017). This SNP resulted in a decrease the transcriptional activity of HAND1 and was 
correlated with Tetralogy of Fallot in the patient (Wang et al., 2017). Septum deviations in 
human hearts have also been correlated to a decrease or loss of function of HAND1 in patients, 
caused by a frameshift mutation in the bHLH domain (Reamon-Buettner et al., 2009). 
Interestingly, two other novel amino acid substitutions of Hand1 were found in patients with 
septal defects, however these substitutions result in an increased ability of HAND1 to form 
homodimers (Cheng et al., 2012). Patients with hypoplastic hearts have also been found to 
have frame shift mutations in the HAND1 bHLH domain which result in a truncated protein 
and ultimately a decrease in the mutant protein levels (Reamon-Buettner et al., 2008). The 
wide range of congenital heart defects resulting from different HAND1 mutations suggest 
HAND1 has a complex role during development of the heart but is nevertheless crucial for its 
proper development.  
1.4.5 Hand1 gain of function experiments  
Due to the lethality of Hand1-null mice, a Hand1 over expression mouse model was created 
as to bypass the lethality to study Hand1 function in heart development (Risebro et al., 2006). 
Hand1 was over expressed using the Hand1 promoter, in order to limit over expression to 
tissues that typically express Hand1 (Risebro et al., 2006). Hearts of Hand1 over expressing 
embryos had disrupted heart morphogenesis, with abnormal looping and elongation of the 
outflow tract as well as defects in left ventricle development (Risebro et al., 2006). To further 
examine the role of Hand1, embryonic stem cells were induced to over express Hand1 which 
resulted in an increase in proliferation of precursor cells and a lack of differentiation. In 
contrast, embryonic stem cells lacking Hand1 had an increase in differentiation towards 
cardiomyocytes (Risebro et al., 2006). Both the in vivo and in vitro results suggest that the role 
of Hand1 in the developing heart is to regulate proliferation and differentiation of precursor 
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cells to ensure proper balance of myocardial precursors required for normal development 
(Risebro et al., 2006).  
Hand1 appears to have a similar regulatory function in trophoblast cells. Over expression of 
Hand1 in trophoblast cells led to an increase in giant cell differentiation, whereas a loss of 
Hand1 in trophoblast cells resulted in a failure of giant cell differentiation and an increase in 
proliferation of precursor cells (Scott et al., 2000). Hand1 appears to have a contradicting role 
in different tissues, as over expression of Hand1 led to an increase in proliferation of cardiac 
precursors, but an increase in differentiation of trophoblast cells to giant cells. However, the 
ability of Hand1 to regulate a balance between proliferation and differentiation in these 
different lineages is consistent.  
Interestingly, Hand1 expression in very low in adult human hearts, however, expression is 
found to increase in patients with cardiac hypertrophy (Breckenridge et al., 2009; Wang et al., 
2017). This increase in Hand1 expression in diseased hearts raises the question whether Hand1 
is a biproduct of this hypertrophy or a cause of it. Breckenridge et al. (2009) created a 
doxycycline-inducible Hand1 cardiac over expression mouse model by generating a transgenic 
mouse where Hand1 expression is regulated by a rtTA-responsive promoter. Doxycycline was 
then used induce Hand1 over expression in hearts of adult mice. This over expression caused 
an increase in cardiac hypertrophy compared to controls and was accompanied by an 
significant increase in mortality of these mice due to a predisposition to ventricular arrhythmias 
(Breckenridge et al., 2009). Furthermore, when the doxycycline treatment was stopped, it led 
to a reversal of cardiac hypertrophy in these mice (Breckenridge et al., 2009). Thus regulation 
of Hand1 is important in terms of both developmental of the heart and in cardiac disease 
phenotypes (Breckenridge et al., 2009; Wang et al., 2017). 
1.5 Rationale  
Hand1 expression begins shortly after gastrulation, and marks the anterior and middle of the 
LPM of Xenopus, however, hand1 is not expressed in the most posterior tail region of the 
embryo, an area which is an area devoid of a vascular plexus (Deimling and Drysdale, 2009). 
Our lab has previously noted a correlation between the size of the developing vascular plexus 
and the hand1 expression domain in Xenopus. Embryonic treatments used to increase or 
decrease the size of the vascularized region of the embryo resulted in a corresponding increase 
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or decrease in the size of the hand1 expression domain, suggesting that hand1 has a role in 
defining the tissue (Deimling and Drysdale, 2011). Furthermore, loss of hand1 expression in 
previously expressed areas of the embryo occurs in a very controlled manner. The most robust 
example of this occurs around stage 32 in Xenopus, when we observe loss of hand1 expression 
along the ventral side of the embryo, in the same location where the ventral blood islands begin 
to form, suggesting that hand1 is playing a role in defining the tissues within the LPM. Given 
the importance of hand1 during development and the strong correlation between hand1 and 
the derivatives of the LPM, we aim to determine the function of hand1 within the LPM of 
Xenopus.  
1.6 Hypothesis and Objectives  
We hypothesize that hand1 is required for normal development of the LPM derivatives in 
Xenopus.  
Objectives:  
1. Create and characterize the phenotype of a hand1 mutant  
2. Create and characterize the phenotype of hand1 over expression model  
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Chapter 2: Materials and Methods  
2.1 Xenopus laevis embryo harvesting  
Female Xenopus laevis were injected with 600-700 IU of human chorionic gonadotrophin 
(Intervet Canada Corporation), depending on the size of the female, to induce ovulation. Eggs 
were collected the following morning and fertilized in vitro in 80% Steinburg’s Solution with 
minced testis harvested from male Xenopus laevis. Embryos were flooded with 20% 
Steinburg’s solution following fertilization, de-jellied in 2.5% cysteine solution pH 8, and 
cultured in 20% Steinburg’s solution.  
Working concentrations of Steinburg’s solution were made by mixing 2000% Steinburg’s 
Stock A (1.16M NaCl, 13mM KCl, 16mM MgS04•7H20, 7mM Ca(NO3)2) and 2000% 
Steinburg’s Stock B (92mM Tris-HCl pH 7.4) in a 1:1 ratio. Stock solutions were diluted with 
dH20 into 200% Steinburg’s for storing male testis, 80% Steinburg’s for fertilization, and 20% 
Steinburg’s for embryo culture.  
Embryonic stages were determined using the standard Xenopus staging table (Nieuwkoop and 
Faber, 1994). For fixation, embryos were fixed in MEMPFA solution (4% paraformaldehyde, 
1mM MgSO4, 2mM EDTA (ethyleneglycol-bis-(β-aminoethyl ether) N’,N’,N’,N’-tetra-acetic 
acid) pH 8.0, 0.1 M MOPS pH 7.4), rocking either at room temperature (RT) for two hours, or 
at 4°C overnight and stored in 100% methanol at -20°C.  
2.2 Single guide RNA generation and synthesis  
Single guide RNAs (sgRNA) targeting the hand1 gene were generated. Cas9 target sites were 
identified in the hand1 gene from the Xenbase Xenopus laevis genome database v9.1, 
identifying 18-20 base pair sequences upstream of a protospacer-adjacent motif (PAM) site 
(3’-NGG-5’) by input into CrisprScan Software (http://www.crisprscan.org/). Due to Xenopus 
laevis being tetraploid, sites conserved between both copies of hand1 (Chromosome 1L and 
1S) were considered, with preference for sequences prior to the bHLH domain. Potential off-
target sites were evaluated by probing the Xenopus laevis genome for similar sequences using 
the website GGGenome, and sequences with one or more base pair mismatches to off-target 
sites in the genome were not considered. Four target sites were obtained, one targeting both 
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chromosomes (sgT1), one targeting specifically the long chromosome (sgT2) and two targeting 
specifically the short chromosome (sgT3 and SgT4; Fig. 7).  
To obtain the functional sgRNA for injection, a two-step PCR and in vitro transcription 
reaction was performed. The PCR reaction was carried out following the PCR conditions listed 
in Table 1. Sequences for each unique forward target oligonucleotide and the universal reverse 
primer are listed in Table 2. Each forward primer contained a T7 RNA polymerase binding 
site, followed by the unique target sequence and a universal reverse sequence. The universal 
reverse primer contained a universal reverse sequence complementary to the forward primer 
and a Cas9 association site as outlined in Figure 8. Following the PCR reaction, 5xPB Buffer 
(QIAgen) and 10µL 3M Na Acetate pH 5, were added to the PCR reaction. The mixture was 
then applied to QIAgen Quickspin PCR Columns, and slow spun (6000rpm) for 30 seconds, 
followed by a fast spin (13,000rpm) for 10 seconds. The flow-through was discarded and 
column fast spun again for 1 minute. To wash the column, 750µL PE buffer was added and 
fast spun for 10 seconds. The flow-through was discarded and the column was fast spun for 5 
minutes. PCR product in the column was incubated with 40µL of EB Buffer warmed to 50°C 
30 seconds before elution by a slow spin for 30 seconds, followed by a 2 minute fast spin. The 
quantity and quality of the PCR product was determined using a Nanodrop and 1% agarose gel 
containing EtBr.  
Using the purified PCR product, an in vitro transcription using T7 RNA polymerase (Ambion 
Megascript Kit) was performed in a 20µL reaction containing 300ng DNA, 2µL of each ATP, 
CTP, GTP and UTP, 2µL 10X reaction buffer and 2µL T7 RNA polymerase, incubating at 
37°C overnight. DNA was removed by incubating reaction with 1µL Turbo DNase 
(Invitrogen) at 37°C for 15 minutes. The sgRNA was then purified using GE Illustra Sephadex 
G-50 NICK columns. Prior to use, columns were equilibrated by washing with 3mL TE Buffer 
pH 8 (10mM Tris pH 8, 1mM EDTA pH 8). The sgRNA reaction mixture was applied to the 
column and allowed to enter gel column completely before the column was washed with 400µL 
TE buffer. When dripping ceased, the sgRNA was eluted by applying 400µL TE Buffer to the 
column and collecting the elute in an Eppendorf tube containing 1mL 100% EtOH and 10µL 
NH4 Acetate (Megascript Kit). 
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Figure 7. Hand1 sgRNA target sites within Xenopus. 
Locations of Hand1 guide sequences on both the 1S chromosome (A) and 1L chromosome 
(B). 
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98°C 30 seconds  
98°C 10 seconds  
x 10 cycles 62°C 20 seconds 
72°C 20 seconds 
98°C 10 seconds  
x 25 cycles 72°C 30 seconds 
72°C 5 minutes  
4°C Hold  
Table 1. PCR cycling conditions for sgRNA template generation. 
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Primer Name Sequence 
sgT1 CAGCTAATACGACTCACTATAGGAAGTAAGGTCTCTCCTGG 
GTTTTAGAGCTAGAAATAG 
sgT2 CAGCTAATACGACTCACTATAAGGGATCAGGCATCATGTGG 
GTTTTAGAGCTAGAAATAG 
sgT3 CAGCTAATACGACTCACTATAAGGATGGGTGCTCAACCCTG 
GTTTTAGAGCTAGAAATAG 
sgT4 CAGCTAATACGACTCACTATAGTAGCTCCCAATCAAGTTCA 
GTTTTAGAGCTAGAAATAG 
Universal 
Reverse Primer 
CAAAATCTCGATCTTTATCGTTCAATTTTATTCCGATCAGGC 
AATAGTTGAACTTTTTCACCGTGGCTCAGCCACGAAAA 
Table 2. Primer sequences for the generation of sgRNA for injection. 
The first nucleotides correspond to the T7 promoter site, which is located at the beginning of 
each sgRNA. Underlined are the unique target sequences corresponding to a region of the 
hand1 gene. Bolded is the universal primer sequences which anneals both the target primers 
and the Cas9 association site located on the universal reverse primer together. The remainder 
of the universal reverse primer sequence is the Cas9 association site.  
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Figure 8. Schematic showcasing the two oligonucleotides used to create the final sgRNA. 
The target oligonucleotide contains a T7 RNA Polymerase promoter, target sequence and 
universal primer sequence. The universal reverse primer contains the complementary universal 
primer sequence, which allows the two strands to anneal during PCR, and the Cas9 association 
site, to form the final functional sgRNA.  
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After inverting the tube several times, the sgRNA was incubated at -20°C for 45 minutes, and 
then -80°C for 15 minutes before centrifugation at maximum rpm for 20 minutes at 4°C. The 
pellet was washed with 70% EtOH, dried on a 55°C heat block and resuspended in 20µL dH2O. 
Quality and quantity of the sgRNA was determined using a Nanodrop and 2% agarose and 
TAE gel containing EtBr. sgRNA was diluted to 1500ng/µL and aliquots were stored at -20°C 
until use.  
Cas9 protein was obtained from PNA Bio Inc. (Cat# CP01-200; Newbury Park, CA). Cas9 
protein was resuspended in 50µL nuclease free H2O according to manufactures instructions 
and aliquots were stored at -20°C until use.  
2.3 Embryo Microinjection  
Embryos to be microinjected were transferred into a 3% Ficoll in 1xMMR solution (1mM 
mgSO4, 2mM CaCl2, 5mM Hepes pH 7.8, 0.1mM NaCl, 0.1mM EDTA pH 8 and 2mM KCl) 
following the de-jelling procedure to ensure stability during the injection process by removal 
of liquid between the fertilization envelope and embryo. After incubation in 3% Ficoll in 
1xMMR at 14°C for 15 minutes embryos were microinjected at the one-cell stage using the 
Microinjector Nanoject 3 (Drummond Scientific Company; Broomall, Pa). Seven nanoliters of 
injection stock were injected into each embryo. For hand1 loss of function, 1.5 ng of Cas9 
protein and 750 pg of corresponding sgRNA were injected per embryo. Injection stock 
solutions were diluted in dH20. sgRNA was heated to 70°C for 2 minutes prior to addition to 
the stock solution. For hand1 gain of function experiments increasing concentrations of 
synthetic hand1 mRNA, either 100pg, 500pg or 1000pg were microinjected per embryo. 
Control embryos were injected with water to control for the injection process itself. After the 
injection process, the embryos were cultured in 3% Ficoll in 1xMMR solution at 14°C for 4 
hours before being transferred to 20% Steinburg’s, where successful injected embryos were 
allowed to develop until the desired stage prior to fixation in MEMPFA.  
2.3.1 Determining Cas9 efficiency  
Before injecting embryos with the hand1 sgRNAs, we sought to assess the function of the Cas9 
protein in Xenopus, as cells quickly divide during embryogenesis. We therefore first designed 
sgRNA targeting the slc45a2 gene (solute carrier family 45 member 2). Slc45a2 is a carrier 
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protein that mediates melanin synthesis (Dooley et al., 2013), therefore knockdown of slc45a2 
would result in embryos lacking melanin providing a direct visual assay to assess Cas9 
function. Slc45a2 was chosen over other melanin production enzymes as slc45a2 is only 
located on the long chromosome, therefore only one pair of chromosomes would need to be 
targeted. The sequence of the forward target oligonucleotide was as follows: 
CAGCTAATACGACTCACTATAGGAGCCTCCCAGAAGATCTAGTTTTAGAGCTAG
AAATAG. The underlined portion corresponds to the target region of the slc45a2 gene and 
the bolded sequence corresponds to the universal primer sequence. Functional sgRNA was 
generated as described previously, and embryos were injected with 7nL of injection stock, 
containing 750pg sgRNA and 1.5ng Cas9 protein. Embryos were then allowed to develop until 
stage 40, when pigmentation is evident, and fixed in MEMPFA before imaging. 
2.4 T7 Endonuclease Assay  
2.4.1 Xenopus DNA extraction 
DNA was extracted from 10 individual embryos at stage 30 every time injections occurred to 
ensure the injections were successful for that day. Embryos were homogenized overnight at 
55°C in homogenization buffer (1% SDS (sodium disulfate), 10mM EDTA pH 8, 20mM Tris 
pH 7.5, 100mM NaCl) containing 0.1mg protease K. Following homogenization, 0.1 volumes 
5M NH4 Acetate was added to the homogenate and DNA was extracted with 1:1 phenol 
chloroform, followed by 1:1 chloroform extraction. DNA was precipitated with 0.1 volumes 
5M NH4 Acetate pH 5 and 0.6 volumes isopropanol, pelleted by centrifugation at high speed 
for 10 minutes. The pellet was washed with 70% EtOH and resuspended DNA was treated with 
0.5µg RNase A for 30 minutes at RT, followed by precipitation in 1 volume isopropanol before 
centrifugation at high speed for 10 minutes. Pellet was dried, and DNA was resuspended in 
20µL dH20.  
2.4.2 T7 Endonuclease Digestion  
To determine the effectiveness of the sgRNA being used, a T7 Endonuclease Assay was then 
performed on the extracted DNA. PCR reactions were performed on extracted DNA, using 
primers that amplified the area of hand1 gene surrounding the sgRNA target sites, one set for 
each the 1S and 1L chromosome. Primers for the T7 Endonuclease Assay were chosen so that 
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the product amplified was 700-800 base pairs, with the sgRNA target site located offset from 
the center of the amplicon so that resolution on a gel would result in two distinct product sizes. 
Primers were as follows: hand1.L Fwd: TGCAGTGTAGACTTTGCCTGGA; hand1.L rev: 
CCTATATTCATACAACCCTACTC; hand1.S Fwd: GCAGCACAGACTGAACCTGG; 
hand1.S Rev: CCAATTTGAGCGATTTCTACTCAC. PCR cycling conditions were as 
follows: denaturing at 95°C for 1 minute, annealing at 55°C (hand1.S) or 59°C (hand1.L) for 
30 seconds, and amplification at 72°C for 30 seconds, repeating the cycle 40 times. Before 
continuing, a sample of the PCR product was run on a 1% agarose gel and TAE containing 
EtBr to ensure a single product was amplified. The remaining PCR product was then denatured 
at 95°C for 1 minute and reannealed by decreasing the temperature 1°C/minute until 4°C was 
reached. After reannealing, 0.3 U of T7 endonuclease enzyme (NEB) and NEB Buffer 2 was 
added to the remaining PCR product and incubated at 37°C for 1 hour. Fifteen microliters of 
the digest were resolved on a 2% agarose gel and TAE containing EtBr at 100V for 50 minutes. 
Mismatched DNA would expect to resolve 3 products on the gel, which would indicate that 
Cas9 cut the DNA at the predicted guide target site.  
2.5 Sequencing of hand1 target region and TIDE Analysis 
PCR products for hand1 gene of extracted single embryo DNA were also sent for sequencing. 
Primers were used as listed above, following the same conditions and the product was purified 
using the QIAgen PCR purification kit following manufactures instructions. PCR product was 
sequenced using both primer sets as in amplification. Electrogram results from sequencing 
were input into the program TIDE (Tracking of Indels by Decomposition; 
https://www.deskgen.com/landing/tide.html) comparing non-injected embryos to embryos 
injected with sg1 alone; sg2 and sg3; or sg2 and sg4. TIDE output was then able to determine 
estimations for the number of mutations, the number of wildtype sequences remaining and the 
number of in-frame mutations for each embryo analyzed.  
2.6 mRNA probe synthesis for whole mount in situ hybridization  
2.6.1 Bacterial competent cell culture and plasmid transformation  
In order to generate competent cells for transformations Escherichia coli (DH5-α) cells were 
grown in 4 mL liquid Luria Broth (LB; for 1L: 10g bacto-tryptone, 5g bacto-yeast extract, 10g 
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NaCl, pH 7) overnight agitating at 37°C. An aliquot of cells was removed and 100-200µL was 
used to inoculate 50mL culture of LB and agitated at 37°C for 4 hours, or until the culture 
reached log phase growth. The cultures were chilled on ice for 20 minutes and pelleted for 10 
minutes at 4°C at 3000 rpm. Cells were re-suspended in 30mL ice cold Solution A (0.1M 
CaCl2, 0.1M MgCl2, 1mM Tris pH 7.5) and left on ice for 20 minutes. Cells were then 
centrifuged at 3000 rpm for 10 minutes at 4°C. The supernatant was removed, and cells were 
resuspended in 2.5mL ice cold Solution B (0.1M CaCl2, 0.1M MgCl2, 1mM Tris pH 7.5, 0.1% 
glycerol) and aliquots were stored at -80°C until use.  
When transforming plasmid into bacteria, 10ng of plasmid was added to 60mL of ice cold 
competent cells. The competent cell/DNA solution was kept on ice for 30 minutes and then 
heat-shocked at 42°C for 90 seconds. Following heat shock, cells were incubated on ice for 2 
minutes before being transferred to 1mL liquid LB and incubated at 37°C for 45 minutes, 
rocking at 225rpm. Two hundred microliters of cells were then plated on LB agar plates (for 
500mL: 5g bacto-tryptone, 2.5g bacto-yeast extract, 5g NaCl, 7.5g bacto-agar) containing the 
antibiotic ampicillin (50mg/mL) and cultured overnight at 37°C. Colonies were then picked 
using a sterile pipette tip and grown at 37°C overnight in 4mL liquid LB, rocking at 225rpm. 
DNA was then isolated from bacterial cells using QIAgen Miniprep Spin Kit, following 
manufactures instructions. 
2.6.2 Restriction Digest of Plasmid  
Plasmids were cut with the appropriate enzymes to yield the template for generating antisense 
mRNA probe. In a reaction volume of 50µL, 15µL plasmid DNA, 28µL dH2O, 5µL of the 
appropriate restriction buffer and 2µL of the appropriate restriction enzyme were incubated at 
37°C for 2 hours. Refer to Table 3 for the specific buffer and enzyme for each cDNA plasmid 
used. Digested DNA was purified by phenol: chloroform extraction. The aqueous layer was 
extracted and precipitated with 0.1 volumes 5M NH4 Acetate and 95% EtOH. DNA was 
pelleted at 14000rpm for 10 minutes and washed with 70% EtOH. DNA was resuspended in 
10µL dH20 and the product from the digestion was visualized by running 1µL of digestion on 
a 1% agarose and TAE gel containing EtBr.  
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2.6.3 In Vitro Transcription of Probe  
Transcription of RNA was carried out with either T7, T3 or SP6 RNA polymerase, depending 
on the probe being synthesized. To a new, clean 1.5mL Eppendorf tube, a 20µL reaction 
containing 1ng linearized plasmid, 1.5µL dH20, 4µL DIG-NTP mix (2.5 mM ATP, 2.5mM 
GTP, 2.5mM CTP, 1.625mM UTP, 0.875mM DIG-11-UTP (Roche)), 4µL 10mM DTT 
(Dithiothreitol), 0.5µL RNase inhibitor (RNase Out (Invitrogen)), 4µL transcription buffer and 
2µL of the appropriate RNA polymerase as seen in Table 3 were added and incubated at 37°C 
for 2 hours. One microliter of DNase I (Invitrogen) was added to the reaction and incubated at 
37°C for 15 minutes. To check the quality of the resultant RNA probe, 1µL was run on a 1% 
agarose and TAE gel containing EtBr. To the remainder reaction, 80µL 1% SDS in TE Buffer, 
15µL 5M NH4 Acetate and 100µL EtOH was added and precipitated on ice until results from 
gel were known. If the quality of the RNA was good, as determined by one clean band on the 
gel, the RNA was then centrifuged at 14000rpm for 15 minutes at 4°C. The supernatant was 
removed by glass pipette and RNA pellet was briefly dried before resuspending in 1mL RNA 
hybridization buffer (50% formamide, 5xSSC (diluted from a 20xSSC stock: 3M NaCl, 0.3M 
sodium citrate, pH 7), 5mM ETDA pH 5, 1mg/mL Yeast RNA extract (Boehringer), 1M 
Denhart’s solution (2% bovine serum albumin, 2% polyvinylpyrrolidone (PVP-40), 2% Ficoll 
40) and 0.1% Tween-20) and warmed to 37°C to help RNA move into suspension. The RNA 
probe was then diluted in a 15mL conical tube with RNA hybridization buffer to 8-15mL 
depending on the level of RNA present as determined by the previous agarose gel. Prepared 
RNA probe was then stored at -20°C.  
2.7 Whole mount in situ hybridization  
Whole mount in situ hybridization was performed on fixed embryos following the protocol by 
Deimling et al. (2015). The procedure was carried out in small glass vials 1.5 cm in diameter 
on LabQuake shakers. All steps were carried out at RT unless specified. Embryos stored in 
methanol were rehydrated in a methanol series (5 minute washes in 75%, 50%, 25%) followed 
by 3 washes for 10 minutes in TTW buffer (tris buffered saline: 50mM Tris pH 7.4, 200mM 
NaCl, 0.1% Tween-20). Embryos were then fixed with MEMPFA for 20 minutes, followed by 
three washes of five minutes each in TTW buffer.  
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Table 3. Restriction enzyme and appropriate buffer for linearizing each plasmid for 
transcription with appropriate RNA polymerase. 
 
 
 
 
 
 
 
 
 
 
Plasmid 
Name 
Vector Restriction 
Enzyme 
Buffer RNA 
polymerase 
ami pBluescript SK KpnI React4 T3 
aplnr pBluescript SK- BamHI React3 T7 
etv2 pGEM-T easy SalI React3 T7 
foxf1 pBluescript II EcoRI React1 T7 
globin pCS107 HindIII React2 T3 
hand1 pKRX BamHI React3 T7 
isl1 pBluescript SK EcoRI React1 T7 
nkx2.5 pGEM 3Z KpnI React4 T7 
scl pGEM7 Xhol React2 SP6 
spib pCMV-Sport6 SalI React3 T7 
tnni3 pBluescript SK EcoRI React1 T7 
 
 
 
40 
To prepare for RNA probe hybridization, embryos were washed for 10 minutes in RNA 
hybridization buffer. RNA hybridization buffer was then replaced with warmed buffer and 
incubated at 65°C for 1 hour. Pre-warmed RNA probe was added to the vials (1.5mL/vial) and 
incubated overnight at 65°C.  
The following day, probe solutions were removed (reused if stored at -20°C) and replaced with 
warmed RNA hybridization buffer for 10 minutes at 65°C. Embryos were then washed twice 
for 20 minutes in 2xSSC at 37°C followed by 3 washes in 0.2xSSC for 1 hour at 65°C. Embryos 
were blocked for 30 minutes in blocking solution (MAB pH 7.5 (100mM maleic acid, 150mM 
NaCl) containing 2% Blocking reagent (Roche; Indianapolis, IN) and 20% sheep serum treated 
for 2 hours at 65°C) and then overnight in blocking solution containing DIG-labelled antibody 
(Cat#11093274910, Anti-Digoxygenin-AP, Fab Fragments; Roche) diluted at 1:5000. The 
following day, embryos were washed 12 times in MAB for 30 minutes. Embryos were then 
stained using BM purple (Roche) as the alkaline phosphatase substrate overnight. The colour 
reaction was fixed in MEMPFA for 30 min followed by three 5 min washes with 25%. 
Embryos were bleached in bleaching solution (5% formamide, 0.5xSSC, 1% hydrogen 
peroxide) for 2-3 hours, until the endogenous pigmentation was removed. Once the bleaching 
solution was removed, embryos were dehydrated in a methanol series and stored in 100% 
methanol at -20°C until imaging.  
2.7.1 Embryo Imaging  
Embryos were rehydrated through a methanol series, transferred in 1xPBS solution and imaged 
on a 1% agarose plate using a Leica M205 FA microscope. Images were captured and 
processed using Leica Application Suite.  
2.8 Whole mount TUNEL staining  
Fixed embryos were rehydrated in a methanol series and then washed twice in 1xSSC. 
Embryos were then bleached in bleaching solution, under direct light for 1-2 hours. Embryos 
were washed twice with PBS/0.1% Tween-20 for 15 mins before incubation with terminal 
deoxynucleotidyl transferase (TdT) Buffer (Thermo Fisher Scientific) for 1 hour. Embryos 
were incubated with end-labeling solution (TdT Buffer, 150U/ml TdT enzyme (Thermo Fisher 
Scientific), 1µM DIG-11-dUTP (Roche)) overnight to label cells undergoing apoptosis. 
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Embryos were washed twice with 1mM EDTA pH 8 in PBS for 1 hour at 65°C, followed by 4 
washes in PBS at RT. Embryos were incubated with blocking solution for 1 hour followed by 
overnight incubation with blocking solution containing anti-DIG antibody coupled to alkaline 
phosphatase diluted to 1:3000 overnight at 4°C. The following day, embryos were washed 5 
times for 1 hour with MAB. Embryos were then washed with AP buffer (100mM Tris pH 9.5, 
50mM MgCl2, 100mM NaCl, 0.1% Tween, 5mM levamisole (Sigma)). Staining was 
developed using the phosphate substrate NBT/BCIP (4.5µL nitro blue tetrazolium (75mg/mL 
70% dimethylformamide) and 3.5µL 5-bromo-4-chloro-3indolyl (50mg/mL 100% 
dimethylformamide) in 1mL AP buffer). Colour reaction was stopped with a MAB wash, and 
embryos were dehydrated in methanol and cleared in benzyl benzoate/benzyl alcohol (2:1 
ratio) for imaging.  
2.9 Synthetic hand1 mRNA synthesis  
2.9.1  Xenopus RNA isolation  
A total of 8 embryos were pooled and used for cDNA library preparation. Embryos at stage 35 
were homogenized in a homogenization buffer consisting of 4M guanidine thiocynate, 25mM 
sodium citrate, 0.5% N-lauroyl sarcosine and 0.1M β-mercaptoethanol. After homogenization, 
0.1 volume of 2M Na Acetate pH 4 was added followed by phenol: chloroform extraction. The 
aqueous layer was removed and 2.5x volume of 70% ethanol was added. This solution was 
then transferred to QIAgen RNeasy spin columns, and RNA was purified according to 
manufactures instructions. RNA concentration and quality were measured using a 
spectrophometer and 1% agarose in TAE gel containing EtBr.  
2.9.2 Cloning of hand1 into pCS2 vector  
Xenopus cDNA was synthesized using Superscript II Reverse Transcriptase (Invitrogen) with 
Oligo-dT primers (Invitrogen) and RNase Out (Invitrogen). One microgram of RNA was used 
for the reaction to generate cDNA. Primers were designed flanking the coding region of the 
hand1 mRNA transcript and restriction sites were added that corresponded to sites in the 
polylinker of the pCS2+ expression vector. The enzyme site for BamHI was added to the 5’ 
end of the forward primer, and the enzyme site for Cla1 was added to the 3’ end of the reverse 
primer. Primers were as follows: fwd: GCGAGGATCCGGAGGTGCCAGAAGTTGTTTTT, 
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Rvs: CTCGCATCGATATCAGGGGTTTAGTTCCAGGG. PCR reaction using 2µl cDNA 
was carried out using Q5 High Fidelity Polymerase (NEB). The following conditions were 
used, DNA was denatured at 95°C for 1 minute, annealed at 57°C for 30 seconds, and amplified 
for 1 minute at 72°C, repeating the cycle 35 times. PCR product was purified using QIAgen 
PCR Purification Kit, following manufactures instructions. The PCR product was verified by 
running 2µl on a 1% agarose in TAE gel containing EtBr. After attaining both the insert and 
the plasmid, restriction digests with the enzymes BamHI and Cla1 were performed. After 
digestion, the vector and insert were gel extracted, and purified using QIAgen gel extraction 
kit, following manufactures instructions. Quantity of vector and insert were determined using 
a spectrophometer. Insert and vector were then ligated overnight using T4 Ligase (Thermo 
Fisher Scientific) and transformed into DH5-α cells as described previously. Colonies that 
formed were picked and grown overnight in LB broth. Plasmids were isolated using QIAgen 
Miniprep Kit, following manufactures instructions and sent for sequencing to ensure there was 
no mutations in the hand1 mRNA prior to mRNA synthesis.  
Xenopus hand1 cDNA was also cloned into a pCS2+MT (myc tag) vector. Insert was generated 
through a PCR reaction using template cDNA and PCR conditions as described above, with 
the following primers Fwd: GCGAGGATCCGGAGGTGCCAGAAGTTGTTTTT, rvs: 
TATACATCGATTGGGGTTTAGTTCCAGGGCC. The forward primer contained a BamHI 
enzyme site on the 3’ end and reverse primer contained a Cla1 enzyme site on the 5’ end. The 
pCS2+MT vector and insert were digested with BamHI and Cla1, gel purified, and ligated 
overnight following the protocol above followed by transformation and isolation of DNA from 
positive colonies. Plasmids containing pCS2+MT hand1 sequence was verified by sequencing 
before mRNA synthesis for injection.  
2.9.3  mRNA synthesis and purification 
The pCS2+ hand1 vector and pCS2+MT hand1 vector were digested using Not1 for 2 hours 
at 37°C to linearize the plasmid after the polyA tail segment. Digest was confirmed by running 
a 1% agarose and TAE gel containing EtBr. One microgram of digested plasmid was 
transcribed using SP6 mMessage mMachine (Ambion), following manufactures instructions. 
After 2 hours incubation with SP6 enzyme mix at 37°C, synthetic mRNA was extracted with 
1:1 phenol: chloroform, followed by extraction with 1:1 chloroform. The aqueous phase was 
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transferred to a clean Eppendorf tube and 1:1 isopropanol was added and incubated at -20°C 
for 15 mins, followed by centrifugation at 4°C for 15 minutes at 14000rpm. The supernatant 
was removed and once dried, the synthetic mRNA was resuspended in 20µl nuclease-free H2O. 
Quality and quantity of mRNA was verified using a 1% agarose and TAE gel containing EtBr 
and Nanodrop, respectively. mRNA was diluted to desired concentrations for injections and 
aliquots were stored at -20°C until use.  
2.10 Western Blot    
Embryos were pooled into groups of 10, and protein was extracted from Hand1-MT injected 
embryos and control embryos at stage 20 and stage 30 of development. Embryos were lysed 
in RIPA buffer (150mM NaCl, 1% Triton-X-100, 1% deoxycholic acid, 0.1% SDS, 1mM 
EDTA, 10mM Tris-HCl, pH 7.5) containing a cocktail of protease inhibitors (1mM PMSF, 
10mM NaF, 10mM NaNO4, 0.1M DTT, 20µM Leupeptin, 20µM Pepstatin and 1µM 
Aprotinin). A syringe with a 25-gauge needle was then used to draw up and push out the 
embryos until a cell lysate was formed. This lysate was then centrifuged at 1000g at 4°C. The 
syringe and needle step were repeated 4 times to the supernatant to completely remove the yolk 
layer. Protein was quantified by Bradford Assay.  
Twenty micrograms of each protein sample were heated at 95°C for 5 min prior to loading on 
a 12% SDS-PAGE gel. A PVDF (polyvinylidene difluoride) membrane was pre-activated with 
100% methanol and washed with transfer buffer (25mM Tris, 192mM glycine) prior to transfer 
of proteins from the gel. Wet-transfer was carried out for 90 min at 200mA. Following transfer, 
the membrane was rinsed with TBST (10mM Tris pH8,150mM NaCl, 0.1% Tween-20) before 
blocking in 5% non-fat dried milk (NFDM) diluted in TBST for one hour at RT. Rabbit anti-
c-Myc primary antibody (Cat# - C3956, Sigma, St. Louie, MO) was diluted 1:500 in 5% 
NFDM and incubated overnight at 4°C. Membrane was washed with TBST before incubation 
with secondary antibody (Goat Anti-Rabbit IgG, horseradish peroxidase conjugated, Cat#- 65-
6120, Thermo Fisher Scientific) for one hour at RT. Membrane was washed with TBST and 
colour reaction using ECL (enhanced chemiluminescence) Western blot Substrate (Thermo 
Fisher Scientific) was carried out prior to protein visualization using a Versa-doc gel system.  
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2.11 Image Analysis  
Due to the mosaicism seen within the embryos, each side of the embryo was used as a separate 
n-value for the measurements, and classification. 
2.11.1   Vasculature Classification 
In order to characterize the formation of the vasculature, embryos were classified into one of 
four categories: normal, mild, moderate and severe, at stage 35 and 37. Vasculature formation 
was based both on size of the vascularized region as well as complexity of the region, with 
severe phenotype determined by less than 5% marker expression in the ventral region of the 
embryo. Moderate vasculature was determined if there was less than 5 branch points within 
the developing vasculature plexus. Mild vasculature was characterized by a combination of 
both 50% of the area of vascular plexus, and/or less than 10 branch points within the 
developing vasculature plexus. Normal vasculature was characterized based on the average 
vasculature marker expression within wildtype control embryos.  
2.11.2     Vasculature Complexity  
To measure the complexity within the vasculature plexus, a line was drawn from the top of the 
cement gland to the point where the proctodeum meets the somites to account for the size and 
position of the embryos. A parallel line was then matched intersecting the bottom of the heart, 
where ImageJ Line Analysis Tool was used to determine the number of times the vasculature 
plexus crossed this line. 
2.11.3    Size of Vasculature Free Zone  
Furthermore, the size of the vasculature free zone of the embryo was measured at Stage 35 and 
37, with the probes aplnr and ami, respectively. To measure the size of the region, a ratio 
between two lines, x and y was used. To obtain the x value, a line of best fit was drawn along 
the end of the vasculature in the ventral region of the embryo, and the length between the 
region where proctodeum meets the somites, to the center of the previous line was the x value. 
The y value was obtained by measuring the length of a line from the bottom of the cement 
gland to the point where the proctodeum meets the somites, to account for the size of each of 
the embryos.  
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2.12 Statistical Analysis  
A one-way ANOVA was used comparing the complexity of the vasculature between hand1 
mutants and control embryos. Similarly, a one-way ANOVA was used to compare the size of 
the vasculature free zone between hand1 mutants and control embryos. A one-way ANOVA 
was also used to compare the size of the blood and myeloid cells between hand1 
overexpressing embryos and control embryos. For all statistical analysis, a p-value < 0.05 was 
considered significant. Statistical analysis was done using GraphPad Prism program.  
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Chapter 3: Results  
3.1 Expression of LPM derivatives throughout development 
As a correlation between the regions where there is loss of hand1 expression in the embryo 
and the differentiation of specific LPM derivatives in those same regions has been only 
partially demonstrated (Deimling and Drysdale, 2011), I decided to more completely document 
the spatial distribution of markers of specific LPM derivatives in parallel with that of hand1 
expression throughout development. Control embryos were fixed at various stages from stage 
20-37 and probed with dig-labelled antisense mRNA probes to visualize expression patterns 
of hand1, etv2 (endothelial precursors), globin (blood), spib (myeloid cells), and ami 
(endothelial cells). 
At stage 20 (Fig. 9) we saw expression of hand1, etv2 and spib. The expression domain of etv2 
at stage 20 overlapped with the expression domain of hand1 along the ventral region of the 
embryo, although hand1 was additionally expressed broadly along the side of the embryo. Spib 
was expressed at stage 20 in a tight cluster of cells marking the aVBI.  
At stage 23 (Fig. 9), spib expressing cells began to migrate away from their initial site of 
differentiation and continued to migrate throughout development until they are located 
throughout the embryo. At stage 23, hand1 expression was located in the middle of the LPM 
and wrapped around the ventral region of the embryo. Similar to that seen at stage 20, etv2 was 
expressed in overlapping regions to that of hand1 expression. At stage 25 (Fig. 9) etv2 
expressing cells appeared to migrate dorsally with loss of both hand1 and etv2 expression along 
the ventral side of the embryo where the pVBI will arise. The expression domain of hand1 at 
stage 25 was still located within the middle of the LPM and the border of hand1 expression 
appeared to overlap with the expression of etv2.  
As development continued into stage 29 (Fig. 10), the expression domain of etv2 continued to 
overlap with the hand1 expression domain, which was seen throughout stages 20-25. At stage 
29 the cells expressing etv2 originating from the ventral side of the embryo migrated into the 
region where the vitelline veins will form, which was also hand1 positive. Additionally, 
expression of hand1 at stage 29 could be seen in the forming heart field, along the anterior side 
of the embryo.  
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Figure 9. Expression pattern of hand1, etv2, spib, globin and ami of WT embryos from 
stages 20-25.   
Control embryos were fixed at stage 20, 23 and 25 and probed with dig-labelled antisense 
mRNA probes against hand1, etv2, spib, globin or ami. Both a side view and ventral view of 
each embryo is shown above. Embryos are oriented with anterior side to the left and posterior 
to the right. At stage 25, expression of hand1 is lost along the ventral side of the embryo, 
following a similar expression of etv2. Spib expressing cells initially are in a restricted domain, 
and then migrate throughout the embryo. Both expression of globin and ami are not yet present. 
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At stage 29 globin expression appeared, marking the pVBI in the classic V-shape along the 
ventral side of the embryo. Of note, expression of globin appears in a region devoid of hand1 
expression.  
At stage 32 (Fig. 10) the vascular plexus began to form and could be visualized by the 
expression of ami, as etv2 expression becomes down regulated once the vascular plexus begins 
formation. Expression of hand1 was still maintained along the broad region of the embryo 
where the vasculature plexus was forming, and within the heart at stage 32 and 35. Expression 
of hand1 did not extend to the most posterior region of the embryo, a region that has been 
termed the vascular free zone as it also does not express either vasculature marker, etv2 or ami. 
At stage 37, the vasculature became more complex, and appeared to be functional as globin 
expression could be seen to migrate throughout vascularized regions of the embryo, and hand1 
expression was still maintained. As the formation of the vitelline veins continued, hand1 
expression appeared speckled in the broad region of the embryo, potentially being down 
regulated in terminally differentiated endothelial cells (Fig. 10).  
3.2 slc45a2 knockdown 
Before beginning to target hand1 in Xenopus using CRISPR technology, we sought to 
determine the efficiency of Cas9 in Xenopus. In order to have a direct visual assay of Cas9 
function, we first targeted the slc45a2 gene, which is required for melanin production. 
Successful mutations in slc45a2 would likely produce albino embryos. When compared to wild 
type controls, slc45a2 mutants exhibited a reduction in melanin when assayed at stage 40 of 
development (Fig. 11A,B). The phenotype of pigmentation loss was classified into four groups: 
none, mild, moderate and severe. The phenotype was considered mild if the embryo had >50% 
pigmentation, moderate if the embryo had <50% pigmentation and severe if the embryo had 
no pigmentation. Compared to non-injected embryos that exhibited 100% normal phenotype, 
slc45a2 mutant embryos had an average of 25% severe, 47% moderate, 27% mild and 7% 
normal pigmentation (Fig. 11C). This variation in phenotype severity was expected due the 
rapid division of Xenopus embryos that could result in different indels created in different cells 
within each embryo. Particularly, non-edited genes, or mutations resulting in a functional 
protein within the embryo would lead to mosaicism of the phenotype.  
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Control embryos were fixed at stage 29, 32, 35 and 37 and probed with dig-labelled antisense 
mRNA probes against hand1, etv2, spib, globin or ami. Both a side view and ventral view of 
each embryo are shown above, with anterior side to the left and posterior to the left. Expression 
of hand1 is maintained throughout development and begins to appear again in the ventral 
region of the embryo around stage 35. etv2 expression begins to disappear as the vasculature 
plexus becomes more defined, and expression of ami first appears, marking the forming 
vasculature plexus. Spib expression is maintained, with cells expressing spib now located 
throughout the embryo. Globin expression begins to appear, and cells remain in the ventral 
blood islands.  
 
 
 
Figure 10. Expression pattern of hand1, etv2, spib, globin and ami of WT embryos from 
stage 29-37. 
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Slc45a2 mutants generated using CRISPR-Cas9 demonstrate the efficiency of the Cas9 protein 
as seen by the lack of pigment (B) compared to full melanin production in the wild type 
embryos (A) at stage 40. Classification of phenotype was determined for each group: mild 
phenotype was characterized by >50% loss of pigment, moderate phenotype was characterized 
based on <50% loss of pigment, and severe phenotype was characterized when there was no 
pigmentation evident on the embryos. Percentage of embryos with each phenotype are 
displayed for both control and slc45a2 injected embryos (C). As approximately 30% of the 
embryos exhibited complete loss of pigmentation, we can conclude that Cas9 is able to 
efficiently knockdown genes of interest in Xenopus.  
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Figure 11. Cas9 efficiency determined by knockdown of slc45a2.  
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3.3 Generation of hand1 mutants 
After establishing the efficiency of Cas9 in Xenopus based on the phenotype of the slc45a2 
mutants, I then proceeded to target the hand1 gene. To ensure the sgRNAs used were targeting 
the correct area of the genome, a T7 Endonuclease Assay was performed. Compared to the 
control embryo (first column on agarose gel; Fig. 12A,B) that had intact DNA, embryos 
injected with Cas9 protein and hand1 sg1 had three bands (either groups of 5 embryos or single 
embryos) indicating that there were mutations in the DNA around the target site caused by 
Cas9 (Fig. 12A,B). Successful cuts were made in 94% of the embryos that were tested from 
various injection days (n=421).  
To further validate the efficiency of the sgRNA used, DNA surrounding the target site of the 
gene was sequenced. The chromatogram of a wild type embryo shows the correct DNA 
sequence around the sg1 target site (labeled with a black line; Fig. 12C). However, when the 
DNA of hand1 mutants was sequenced, the chromatogram becomes unreadable after the PAM 
site (labeled with a red line), indicating that there is a mixture of sequences after the PAM site 
as a result of multiple different mutated copies of DNA (Fig. 12D). Furthermore, when the 
reverse sequence was amplified (displayed is the reverse compliment sequence; Fig. 12E) it 
was evident that the gene was only altered in the region surrounding the PAM site, as the 
remaining sequence of the hand1 gene is intact after that region.  
The chromatograms for each guide were compared using TIDE analysis and TIDE indicated 
that each of the guides used modified the DNA in a mosaic fashion. The average number of 
indels estimated by TIDE for each guide sequence, from an average of 3 single embryos, was 
7 unique sequences for each embryo. Efficiency predictions for each guide was based on the 
percent of the DNA that was mutated within each embryo. Sg1 was predicted to have 85% 
efficiency for both chromosome 1S and 1L, creating an average of 65% out-of-frame mutations 
in chromosome 1L and 54% out-of-frame mutations in chromosome 1S (Fig. 12F,G). Sg2 was 
predicted to have 92% efficiency, with an average of 86% out-of-frame mutations chromosome 
1L (Fig. 12H). Sg3 was predicted to have 93% efficiency, with 66% out-of-frame mutations in 
chromosome 1S (Fig. 12I). Lastly, sg4 was predicted to have 28% efficiency, with 7% out-of-
frame mutations in chromosome 1S (Fig. 12J).  
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DNA was extracted from hand1 knockout embryos and a T7 assay was performed on either 
pools of five or single embryos. Compared to controls, embryos injected with sg1 resolve 3 
bands on the gel indicating the DNA has been mutated, compared to the one band in WT 
controls (A,B). Chromatogram from Sanger sequencing results, first showing the hand1.S 
sequence surrounding the sgRNA target site from a control embryo, the sgRNA site is 
underlined in black, while the associated PAM site is underlined in red (C). Both the forward 
(D) and reverse complementary sequence (E) of one hand1 mutant embryo is shown, where it 
is evident that the DNA has undergone mutations near the PAM site. The reverse 
complementary sequence shows that correct sequence is re-aligned shortly after the PAM site, 
indicating only indels surrounding the sgRNA target site were introduced in the DNA. When 
chromatographs were compared using the program TIDE, estimations of the percent of in-
frame mutations, out-of-frame mutations and DNA with no-editing are reported for each hand1 
sgRNA target (F-J).   
 
 
 
 
 
 
 
 
 
 
Figure 12. sgRNA targeting hand1 are effective at mutating Xenopus DNA. 
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To assay the expression domain of hand1 in hand1 mutants, embryos were probed with dig-
labelled antisense mRNA against hand1 at stage 20. There was no observable difference in the 
expression domains of hand1 compared to control embryos (Fig. 13). Staining for hand1 
appeared to be less intense in hand1 mutants, although this is not a strictly quantifiable measure 
of hand1 expression levels within the embryo.    
3.4  hand1 mutant phenotype 
3.4.1     hand1 loss disrupts heart morphogenesis 
After establishing a knockdown of hand1, I first examined heart development in the hand1 
mutants. Embryos were fixed at stage 35, when looping morphogenesis has normally been 
completed and probed with dig-labelled antisense mRNA against tnni3, a myocardial-specific 
transcript. A schematic showcasing normal rightwards heart looping is shown in Fig. 8A. 
Representative images for each experimental group are displayed (Fig. 14 B-I). Heart looping 
was classified into three groups based on phenotype severity: normal, defective looping and 
linear. Hearts were considered to have looped normally if looping occurred to the right, hearts 
were classified as having defective looping if the linear heart tube had begun looping but the 
loop was not as tightly coiled as it is in normal looping, and hearts were classified as linear if 
there was no obvious looping. Percentages for each phenotype are displayed for each 
experimental group. Non-injected embryos show 100% normal looping and water injected 
embryos show 92% normal looping. However, sg1 injected and sg1,2,3 injected embryos show 
an increase in both defective looping and linear phenotypes, with 33% of sg1 hearts having 
defective looping and 25% linear heart tubes, and 30% of sg 1,2,3 injected hearts with defective 
looping and 46% linear heart tubes (Fig. 14J).   
As nkx2-5 and isl1 are factors known to be involved in heart looping morphogenesis, I next 
examined the expression of both nkx2-5 and isl1 in the hand1 mutants. Changes in the size of 
these expression domains could lead to defects in heart morphogenesis. Compared to controls, 
there was no discernible difference in the expression patterns of nkx2-5 or isl1 in sg1,2,3 
injected embryos when assessed at stage 18 (Fig. 15).  
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Figure 13. Hand1 mutants show similar hand1 expression patterns.  
Embryos were fixed at stage 20 and probed with dig-labelled antisense mRNA probes for 
hand1. Both a side (A, C, E, G) and ventral view (B, D, F, H) of each embryo is shown. 
There appears to be no change in hand1 expression domain between control embryos (A-D) 
and hand1 mutants (E-H).  
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Figure 14. Loss of hand1 disrupts heart morphogenesis.  
Schematic showcasing heart looping of a stage 35 embryo, where the linear heart tube has 
looped to the right (A). Embryos were fixed at stage 35 probed with dig-labelled antisense 
mRNA probes against tnni3 transcripts. Shown is a ventral view of the embryos. Control 
embryos display a similar rightwards heart looping (B-E) while hand1 mutants display 
disturbed heart looping, with an increase in cardiac edema (F-I). Phenotypes of the heart were 
classified into 3 groups; normal looping, when the heart was observed to loop to the right, 
moderate, which was characterized based on the extent of reduced looping, H being an example 
of moderate looping, where the heart has incomplete heart looping, and lastly, linear, where 
the heart had no indication of looping morphogenesis occurring (J).  
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Figure 15. Loss of hand1 does not impact differentiation or size of heart fields.  
Embryos were fixed at stage 18 and probed with dig-labelled antisense mRNA probes against 
nkx2-5 and isl1 transcripts. No differences in the primary heart field marker nkx2-5 was found 
between control (A,B) and hand1 mutant embryos (C). No differences in the secondary heart 
field marker, isl1, were found between control (D,E) and hand1 mutant embryos (F).  
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3.4.2     hand1 loss decreases vasculature plexus size and complexity 
To examine the formation of the vasculature plexus embryos were probed at stage 35 and 37, 
with dig-labelled antisense mRNA against aplnr and ami transcripts, respectively. To quantify 
the phenotype of the hand1 mutants, vasculature formation was grouped into four different 
classes: normal, mild, moderate, and severe. Representative images for each classification are 
shown in Figure 10A. The frequency of each phenotype is displayed for each of the 
experimental groups at both stage 35 (Fig. 16B) and 37 (Fig. 16C). Embryos injected with sg1 
or sg1,2,3 had an increase in the percentage of embryos exhibiting mild, moderate and severe 
phenotypes as compared to control embryos (Fig. 16B,C). Interestingly, there was a further 
increase in the severe phenotype for sg1,2,3 injected embryos as compared to sg1 injected 
embryos (Fig. 16C).  
The size of the non-vascularized region at the posterior end of the embryo was then compared 
in order to quantify the overall size of the plexus being formed in the embryos. To standardize 
and quantify the region, a ratio of x (length from where the proctodeum meets the somites to 
the middle of the line of best fit along the end of the vasculature) /y (length from the cement 
gland to where the proctodeum meets the somites) was compared between the embryos (Fig. 
17A,B). There was a significant increase in the size of the non-vascularized region in hand1 
mutant embryos both stage 35 (Fig. 17C) and stage 37 (Fig. 17D). Furthermore, the size of the 
non-vascularized region in sg1,2,3 injected embryos was significantly greater when compared 
to sg1 injected embryos and controls at stage 37 (Fig. 17C).  
To quantify the complexity of vasculature plexus, a line analysis was used to determine the 
number of intersection points between an artificial line through a standardized position on the 
embryo and the vasculature plexus (Fig. 18A,B). When quantified, there was a significant 
decrease in the number of intersection points in hand1 mutants as compared to control embryos 
(Fig. 18C). Therefore, loss of hand1 results in a decreased size and complexity of the vascular 
plexus within Xenopus embryos.  
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Figure 16.  Loss of hand1 disrupts vasculature formation.  
Embryos in both control and hand1 mutant groups were classified into one of four groups 
based on the complexity of the vascular plexus: normal, mild, moderate and severe, at stage 35 
and 37 with either the probe aplnr or ami, with a representative image of each classification 
shown (A). Percent of embryos in each classification are shown for stage 35 (B) and stage 37 
(C). At both stages, there was an increased frequency of mild, moderate and severe phenotypes 
in hand1 mutants as compared to control embryos. Embryos are oriented with anterior to the 
right, posterior to the left.  
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Figure 1.  Loss of hand1 disrupts vasculature formation.  
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Embryos were fixed at stage 35 and 37 and probed with dig-labelled antisense mRNA probes 
against aplnr and ami, respectively. Size of the non-vascularized region was measured as a 
ratio of x/y for all embryos (A-B). Embryos are oriented with anterior to the right, posterior to 
the left. In each case, in the hand1 mutants, the area of the non-vascularized region was 
increased at both stage 35 (C; student’s t-test, p>0.01) and stage 37 (D; one-way ANOVA, 
p>0.01), with different lowercase letters representing statistically significant differences.  
 
 
 
 
 
 
R
at
io
 b
et
w
ee
n 
x/
y
Non-Inj Water Inj sg 1 inj sg 2,4 inj sg 1,2,3 inj
0.0
0.2
0.4
0.6
a a
b b
c
n=68 n=41 n=88 n=38 n=55
Water-inj sg1 inj
0.0
0.2
0.4
0.6
R
at
io
 b
et
w
ee
en
 x
/y ****
n=80n=57
C
 
D
 
Figure 17. Loss of hand1 increases the size of the non-vascularized region. 
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Figure 18. hand1 mutants show a decrease in complexity of the vasculature plexus.  
Embryos were fixed at stage 37 and probed with dig-labelled antisense mRNA probes against 
ami. Complexity was measured based on number of times the vasculature intersected along a 
line across the middle of the embryo (A-B). Embryos are oriented with anterior to the right, 
posterior to the left. Hand1 mutants showed a significant decrease in number of line 
intersections as compared to the non-injected and water injected controls (C; one-way 
ANOVA, p>0.001), with different lowercase letters representing statistically significant 
differences.  
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3.4.3     hand1 loss decreases the number of differentiated endothelial cells 
Next, to discern potential causes for the reduced vasculature plexus formation, I examined 
earlier time points in development to determine if the vasculature was reduced at earlier stages. 
First, I looked at stage 28 of development using a dig-labelled antisense mRNA probe against 
etv2 transcripts as they are a marker of early endothelial cells. Control embryos at this stage 
showed etv2 expression in the cardinal vein and vitelline vein region (Fig. 19A,B). When 
examining etv2 expression from the ventral side of the embryo, the endothelial cells created a 
defined "border" surrounding the blood islands (Fig. 19C). The expression of etv2 within the 
cardinal vein appeared unchanged in both sg1 and sg1,2,3 injected embryos (Fig. 19D,G). 
However, the vasculature within the broad region of the hand1 mutant embryos appeared to 
have a reduced number of endothelial cells (Fig. 19E,H), and similarly had a less dense 
“border” surrounding the ventral blood islands (Fig. 19F,I).  
Given the decrease in endothelial cells at stage 28, I then examined expression of etv2 even 
earlier in development. In situ hybridization demonstrating etv2 expression at both stage 23 
and 25 shows the earliest endothelial cells populations. In control embryos, ventral etv2 
expression at stage 23 formed a wide V-shape just posterior of the cement gland (Fig 20A, B, 
E, F). Although etv2 expression was evident in hand1 mutants the wide V-shape was less dense 
and appeared smaller in size compared to controls (Fig 20 I, J, M, N). At stage 25, etv2 
expression in controls was more dense in the vitelline vein region of the embryo, with minimal 
expression on the most ventral side of the embryo (Fig 20C, D, G, H). In hand1 mutants at 
stage 25, etv2 expression appeared more sparse within the broad region of the embryo, however 
there was no change in the location of etv2 expression within these embryos (Fig 20K, L, O, 
P). Thus, the loss of hand1 affects the early formation of vasculature cells within the embryos.  
To determine if the decrease in endothelial cells was due to increased apoptosis of endothelial 
cells in the embryos, a whole-mount TUNEL assay was performed on stage 28/30 embryos. 
Slc45a2 sgRNA and Cas9 injected embryos were used as an additional control for Cas9 
function as it has recently been shown that double stranded breaks created by Cas9 may 
activate the p53 pathway triggering cell death (Haapaniemi et al., 2018; Ihry et al., 2018).  
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Figure 19. Loss of hand1 decreases number of endothelial cells in the LPM.  
Control embryos and hand1 mutants were fixed at stage 30 and probed with dig-labelled 
antisense mRNA probes against etv2. Both side view (A, D, G), enlarged side view (B, E, H) 
and ventral view (C, F, I) of each embryo is shown above, with anterior to the right, posterior 
to the left. Control embryos show a large number of endothelial cells within the LPM (A,B), 
forming a fine boarder along the ventral side of the embryo (C). Hand1 mutants show both a 
decrease in number of endothelial cells (D-E, G-H), and loss of populated boarder surrounding 
the ventral blood islands (F,I).   
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Figure 20. Loss of hand1 reduces the population of differentiated endothelial cells.  
Control embryos and hand1 mutants were fixed at stage 23 and 25 and probed with dig-labelled 
antisense mRNA probes against etv2 to observe endothelial cells prior to vascular plexus 
formation. Both side view (A, C, E, G, I, K, M, O) and ventral view (B, D, F, H, J, L, N, P) of 
each embryo are shown, oriented anterior to the right, posterior to the left. Control embryos at 
both stages show a large population of differentiation endothelial cells within the ventral region 
of the embryo (A-H). Loss of hand1 does not disturb the localization of the endothelial cells 
within the embryo, but reduces the population of cells within these areas (A-P). 
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Apoptosis patterns observed in all embryos are similar to that as reported in the literature, with 
apoptotic cells located in the neuronal, midbrain, and optic nerve regions of the embryo 
(Hensey and Gautier, 1998). However, there appeared to be no apoptosis occurring in the broad 
region where hand1 is normally expressed in either hand1 mutants or control embryos (Fig. 
21), thus the decrease in endothelial cells observed in hand1 mutants is likely not due to 
increases in cell death. 
3.4.4     hand1 loss does not affect hematopoietic development 
As I have shown that Hand1 has a vital role in both heart and vasculature formation in Xenopus, 
the role of Hand1 in the development of other LPM derivatives was examined.  
To observe the differentiation of myeloid cells, embryos were fixed at both stage 20 and stage 
34 and probed with dig-labelled antisense mRNA against spib. At stage 20, spib was expressed 
in a compact region at the anterior ventral side of the embryo (Fig. 22A). There was no 
difference in the expression domain of spib between control and hand1 mutant embryos (Fig. 
22A, C, E). Similarly, no differences in expression of spib were observed at stage 34 between 
control and hand1 mutant embryos (Fig. 22B, D, F), therefore loss of hand1 does not appear 
to affect the differentiation or migration of the myeloid cells marked by spib.  
To assess the differentiation of blood cells, dig-labelled antisense mRNA probes for scl and 
globin were used against stage 34 embryos. There was no observable difference in expression 
of either scl or globin (Fig. 23). Thus, Hand1 does not appear to affect the differentiation of 
the blood cell lineages.  
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Figure 21. Loss of hand1 does not increase apoptosis within the LPM.  
Control embryos and hand1 mutants were fixed at stage 28/30 of development, and TUNEL 
assay was performed to determine the number of apoptotic cells. Embryos are oriented with 
anterior to the right, posterior to the left. Both control (A-D) and hand1 mutant (F-I) embryos 
show a normal pattern of apoptosis for their developmental stages. Although CRISPR injected 
embryos appear to have an increase number of positive nuclei as compared to controls at stage 
28, there is no positive nuclei within the hand1 positive region of the LPM.  
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Figure 22. Loss of hand1 does not affect the differentiation of myeloid cells as marked by 
expression of spib.  
Control embryos and hand1 mutant embryos were fixed at both stage 18 and 35 and probed 
with dig-labelled antisense mRNA probes against spib. Stage 34 embryos are oriented with 
anterior to the left, posterior to the right. No differences in differentiation of lineages 
expressing spib were observed between the control embryos (A-D) and hand1 mutants (E-F).  
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Figure 23. Loss of hand1 does not affect the differentiation of blood lineages 
as marked by scl and globin.  
Control embryos and hand1 mutant embryos were fixed at stage 35 and probed with dig-
labelled antisense mRNA probes against globin and scl. Both a side view (A, C, E, G, I, K, M, 
O) and ventral view (B, D, F, H, J, L, N, P) of each embryo is shown above. Embryos are 
oriented with anterior to the left, posterior to the right. No differences in differentiation of 
lineages were observed between the control embryos (A-H) and hand1 mutants (I-P).  
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3.5 Consequences of hand1 over expression 
To further explore the role of Hand1 in development of the lateral plate in Xenopus, a hand1 
over expression model was used. This was accomplished by injecting synthetic hand1 mRNA 
into embryos and assessing the differentiation of LPM derivatives. To confirm that synthetic 
hand1 mRNA was present in embryos, a whole mount in situ hybridization was performed on 
injected embryos at stage 20, probing for hand1. Compared to control embryos who exhibit 
normal hand1 expression patterns (Fig. 24A-C), there was an increase in hand1 expression in 
all embryos injected with synthetic hand1 mRNA (Fig. 24D-F, K-M). This was based on both 
staining intensity and distribution. Embryos injected with synthetic hand1 mRNA had 
expression of hand1 throughout the entire embryo indicating that the injections were 
successful. Furthermore, a portion of the embryos injected with hand1 were observed to have 
an increase in hand1 expression in only one half of the embryo (Fig. 24G-J). Increased 
expression in one half of the embryo suggests that the mRNA injected did not diffuse 
throughout the cell prior to the first cell division, thus rendering only half of the embryo 
containing synthetic hand1 mRNA.  
To confirm that the hand1 mRNA was being translated into protein, a western blot was 
performed probing for Hand1-MT protein at stage 20 and stage 30. Hand1-MT protein, as seen 
by the band at 40kD was detected at both stage 20 and stage 30 in embryos injected with 
synthetic hand1-MT mRNA and was not detected in control embryos (Fig. 24N).  
3.5.1.    hand1 overexpression disrupts heart morphogenesis 
To assess the effects of hand1 over expression on heart morphogenesis, a whole mount in situ 
hybridization was performed on stage 35 embryos using dig-labelled antisense mRNA probe 
against tnni3. Embryos over expressing hand1 had defects in heart morphogenesis 
accompanied by an increase in cardiac edema (Fig. 25A-J). Defects in heart morphogenesis 
were classified into three groups: normal rightward looping, defective looping (determined if 
there was incomplete looping or leftward looping), and linear heart tubes. Control embryos 
exhibited normal heart looping in 90% of the embryos, compared to hand1 over expressing 
embryos which exhibited 10% linear, 40% defective looping and 50% normal phenotype when 
injected with 100pg or 500pg of synthetic hand1 mRNA, and 35% linear, 35% defective 
looping and 30% normal phenotypes when injected with 1ng of synthetic hand1 mRNA.  
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Figure 24. Embryos over expressing hand1 display an increase in hand1 mRNA 
throughout the embryo and the mRNA is being translated into protein.  
Control embryos and hand1 over expressing embryos were fixed at stage 20 and probed with 
dig-labelled antisense mRNA probes against hand1 transcripts. A side view (A, D, G, K, J) 
ventral view (B, E, H, L) and dorsal view (C, F, I, M) are shown of each embryo. Control 
embryos show normal hand1 expression that appears as a saddle shape along the middle of the 
LPM (A-C). Embryos over expressing hand1 lose this expression pattern, and instead have 
hand1 expressed throughout the embryo (D-F, K-M). Some embryos were also shown to have 
only increased expression in one half of the embryo, with one side of the embryo displaying 
the normal hand1 expression pattern (G), while the opposing side had a ubiquitous expression 
pattern (J), which is most evident in the ventral (H) and dorsal (I) photos. The one-sidedness 
suggests that hand1 mRNA was introduced later during the 1-cell stage, and only was present 
one of the two cells after the first division in those embryos, leading to only half of the embryo 
showing increased hand1 transcripts later on in development. Myc-tagged-Hand1 protein is 
correctly translated to yield the Hand1 protein as seen by the 40kB band in OE embryos at 
stage 20 and stage 30, which is not detected in the control embryos (N).  
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Figure 25. Over expression of hand1 causes defects in heart morphogenesis. 
Control embryos and embryos injecting with varying amounts of hand1 mRNA (100pg, 500pg, 
1ng) were fixed at stage 35 and probed with dig-labelled antisense mRNA probes against tnni3 
to visualize heart shape. Ventral view of the embryos are shown. Compared to the control 
embryos which showcase looping of the heart towards the right (A-D), embryos over 
expressing hand1 show a range of defects, from loss of looping to leftward looping, along with 
an increase in cardiac edema (E-J). Phenotypes of the heart were classified into 3 groups; 
normal looping, when the heart was observed to loop to the right, moderate, which was 
characterized based on the extent of looping, where the heart appears to begun to loop, but not 
complete, and lastly, linear, where the heart had no indication of looping morphogenesis 
occurring. Percentage of each phenotype is displayed for each experimental group (K).  
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To examine if hand1 over expression resulted in changes in altered expression of other genes 
involved in heart looping, embryos were probed with dig-labelled antisense mRNA against 
nkx2-5 at stage 20. There was no observable difference in expression of nkx2-5 in embryos 
over expressing hand1 as compared to control embryos (Fig. 26).  
3.5.2     hand1 over expression does not affect vascular plexus formation 
In order to assess the effect of hand1 overexpression on vasculature development, in situ 
hybridization to assess expression of ami was performed at stage 37. Over expression of hand1 
had no apparent effect on vasculature formation within the embryo (Fig. 27). When looking at 
earlier vasculature plexus formation at stage 28 using the probe etv2, there was no observable 
difference in etv2 expression in hand1 over expressing embryos as compared to controls (Fig. 
28). At both stages, ectopic hand1 expression did not result in ectopic expression of vasculature 
markers, thus hand1 does not appear to be sufficient to drive endothelial cell differentiation.  
3.5.3     hand1 over expression decreases differentiation of hematopoietic cells 
In order to assess the differentiation of blood in hand1 over expressing embryos, embryos were 
probed with scl at stage 28. There did not appear to be any change in expression domain of scl 
in embryos over expressing hand1 as compared to controls (Fig. 29). In contrast, embryos over 
expressing hand1 showed a reduction in the size of the globin expression domain as compared 
to non-injected controls (Fig. 30A-P). The area of globin expression was measured as a ratio 
between the area of the globin expression (a’) compared to the area of the embryo (a) as 
illustrated in Figure 30C. There was a significant decrease in the ratio between the area of 
globin expression as compared to the area of the embryo (Fig. 30Q).  
To assess the differentiation of myeloid cells in hand1 over expressing embryos, embryos were 
probed by in situ hybridization for spib transcripts at stage 20, when the myeloid cells are still 
compact within the embryo. Embryos over expressing hand1 appeared to have a decrease in 
the size of the expression domain of myeloid cells as compared to non-injected controls (Fig. 
31A-F). When the size of spib expression was measured as a ratio between the area of spib 
expression (a’) compared to the size of the embryo (a) as seen in Figure 31A. A significant 
decrease in the size of the spib expression domain was confirmed in embryos injected with 
500pg of synthetic hand1 mRNA as compared to controls (Fig. 31G).  
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Figure 26. Over expression of hand1 does not affect differentiation of the heart field as 
marked by nkx2-5 expression. 
Control embryos and embryos over expressing hand1 were fixed at stage 20 and probed with 
dig-labelled antisense mRNA probes against nkx2.5. There appears to be no difference in the 
expression of nkx2.5 between control embryos (A-C) and hand1 over expressing embryos (D-
F).  
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Figure 27. Overexpression of hand1 has no apparent effect on vascular plexus 
formation.  
Embryos were fixed at stage 37 and probed with dig-labelled antisense mRNA probes against 
ami transcripts. Over expression of hand1 (C-F) does not appear to affect vasculature formation 
as compared to control embryos (A-B). Embryos are oriented with anterior to the left, posterior 
to the right.  
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Figure 28. Over expression of hand1 has no observable effect on endothelial cell 
differentiation.  
Control embryos and embryo overexpressing hand1 were fixed at stage 28 and probed with 
dig-labelled antisense mRNA probes against etv2 transcripts. Both side view (A-C, G-I) and 
ventral view (D-F, J-L) of each embryo are shown. No apparent differences in endothelial cell 
differentiation were observed between control embryos (A-F) and hand1 over expressing 
embryos (G-L). Embryos are oriented with anterior to the right, posterior to the left. 
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Figure 29. Hand1 over expression does not impact blood cell progenitors.  
Control embryos and embryo over expressing hand1 were fixed at stage 28 and probed with 
dig-labelled antisense mRNA probes against scl transcripts. Both side view (A, C, E, G) and 
ventral view (B, D, F, H) of each embryo are shown above. No apparent differences in blood 
cell progenitor cells were observed between control embryos (A-D) and hand1 over expressing 
embryos (E-H). Embryos are oriented with anterior to the right, posterior to the left. 
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Figure 30. Over expression of hand1 does not impact blood cell differentiation but 
alters the size of the globin expression domain.  
Control embryos and embryo over expressing hand1 were fixed at stage 28 and probed with 
dig-labelled antisense mRNA probes against globin. Both a side view (A, B, E, F, I, J, M, N) 
and ventral view (C, D, G, H, K, L, O, P ) of each embryo are shown above. There appeared 
to be a decrease in globin expression in hand1 over expressing embryos (I-P) as compared to 
control embryos (A-H). Area of globin expression (a’) was measured as a ratio compared to 
the area of the whole embryo (a), as illustrated in (C). There was a significant decrease in the 
ratio between a’/a for both embryos injected with either 100pg or 500pg hand1 mRNA as 
compared to controls (J; one-way ANOVA, p>0.001). Embryo are oriented with anterior side 
to the right, posterior to the left. 
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Figure 31. Hand1 does not affect differentiation of myeloid cells.  
Control embryos and embryo over expressing hand1 were fixed at stage 20 and probed with 
dig-labelled antisense mRNA probes against spib transcripts. Spib expressing cells appear to 
be more compact when hand1 is over expressed (D-F) as compared to control embryos (A-C), 
however over expression of hand1 does not appear to ablate spib expression. Area of spib 
expression (a’) was measured as a ratio compared to the area of the whole embryo (a), as 
illustrated in (A). There was a significant decrease in the ratio between a’/a for both embryos 
injected with 500pg hand1 mRNA as compared to controls (G; one-way ANOVA, p>0.001).  
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Chapter 4: Discussion  
This study investigated the role of Hand1 in development of the LPM in Xenopus by analyzing 
the differentiation of LPM derivatives in hand1 loss of function and over expression models. 
Our results show that the role of Hand1 in heart morphogenesis is conserved. Hand1 does not 
appear to function by specifying cardiac cell fate but is required for proper morphogenesis. 
Additionally, Hand1 is required for formation of a complex vasculature plexus by maintaining 
a large endothelial cell population early in development. Finally, we showed that 
downregulation of Hand1 is critical for proper development of the hematopoietic lineages in 
Xenopus. The molecular mechanisms behind Hand1 function remain elusive and more studies 
are warranted for further identification of targets and functions of Hand1, but this study 
provides guidance as to which lineages may contain important Hand1 targets.  
4.1 Confirming CRISPR applicability in Xenopus  
Confirmation of CRISPR-Cas9 efficiency was demonstrated by knockdown of slc45a2 which 
provided a direct assay for Cas9 function. Approximately 25% of embryos displayed complete 
loss of pigmentation, while the remaining embryos exhibited mosaic phenotypes suggesting 
that a successfully mutated gene is not typically achieved at the one cell stage, but instead at 
the two or four cell stage. This is in line with other studies, where knockdown of genes required 
for pigmentation, either tyrosinase or slc45a2, in Xenopus tropicalis and Xenopus laevis, show 
similar levels of mosaicism (Delay et al., 2018; Guo et al., 2014; Shigeta et al., 2016). 
Mosaicism can be attributed to either untargeted alleles or mutations that do not alter protein 
function (Delay et al., 2018; Guo et al., 2014; Shigeta et al., 2016).  
TIDE analysis on hand1 mutant embryos indicated that there was an average of seven different 
sequences within each embryo, providing more evidence that Cas9 was introducing different 
indels in the DNA of separate cells. Deletions were the most common mutation, while 
insertions and base pair changes were more rare, which is similar to what is noted in other 
studies (Delay et al., 2018; Shigeta et al., 2016). The frequency of mosaicism can be attributed 
to the rapid division of Xenopus embryos, although a study has shown that all embryos had 
mutations in their genome two hours post Cas9-sgRNA injection, thus formation of the 
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majority of indels is occurring early in development rather than at later stages (Bhattacharya 
et al., 2015).  
The overall effectiveness of each sgRNA as estimated by TIDE showed that sg1, sg2 and sg3 
were highly effective at causing indels in the target region of the genome, with sg2 producing 
the greatest frequency of out-of-frame mutations compared to the other guides. Furthermore, 
sg4 was shown to only have an 28% efficiency, with majority of the sequence unedited. 
Differences in sgRNA efficiency have been noted in other studies, and have been attributed 
the GC content of the guide, the binding affinity of the sgRNA to Cas9 and the location of the 
target site on the chromosome (Bassett et al., 2013; Wang et al., 2014). The location of target 
site is predicted to be more efficient in non-transcribed regions compared to transcribed regions 
of the gene and also predicted to be less efficient the closer the target site is to the last exon 
(Wang et al., 2014). Therefore, these could be potential reasons as to why sg4 had a very low 
efficiency as compared to the other three sgRNAs tested. TIDE analysis therefore holds a great 
importance in determining the effectiveness of sgRNA in Xenopus, in addition to the T7 
endonuclease assay.  
Notable differences exist in the utilization of the CRISPR/Cas9 system for generation of 
mutant embryos between mice and Xenopus. In mice models, Cas9 and sgRNA can similarly 
be injected into a zygote, transplanted back into a surrogate mother to produce chimera 
offspring (Wang et al., 2013; Yang et al., 2014, 2013). However, these mice need to undergo 
further breeding and genetic transmission to produce a homozygous mutant embryo (Wang et 
al., 2013), and this mutant embryo is thus studied further. In contrast, the CRISPR/Cas9 system 
when utilized in Xenopus can easily produce a large number of mutant embryos within a very 
short time (about one week), thus providing an inexpensive tool to knockdown genes of 
interest. However, the one disadvantage of this method is that the pooled population of mutant 
embryos generated will be mosaic, thus instead of studying the effects of one particular 
mutation as one would in mice mutant embryos, the pooled population of Xenopus mutant 
embryos result in a broad range of phenotypes. However, because of the large number of 
mutant embryos that can be generated, the frequency of phenotypes can be classified based on 
severity and thus still provide valuable information on the function of the gene of interest.  
There is currently no antibody that recognizes Hand1 in Xenopus, thus we were unable to assess 
the effectiveness of the knockdown by protein detection. Therefore, we sought to determine if 
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there was a change in the mRNA levels of hand1. However, no observable differences were 
found hand1 mRNA expression patterns within hand1 mutant embryos as compared to 
controls. Embryos injected with sg1,2,3 appeared to have a speckled expression pattern of 
hand1 suggesting that hand1 mRNA levels may be decreased, however this was not 
quantifiable. Non-sense mediated decay, could account for a potential decrease in hand1 
mRNA levels. Non-sense mediated decay is mediated by targeting mRNA with a premature 
stop codon for degradation (Popp and Maquat, 2016). However, the premature stop codon must 
be located more than 50-55 nucleotides upstream of an exon-exon junction to be recognized 
(Nagy and Maquat, 1998; Popp and Maquat, 2016). As hand1 is only comprised of two exons, 
and the target sites are approximately 450-500 nucleotides upstream of the exon-exon junction, 
non-sense mediated decay could be playing a role in the stability of the hand1 transcript, and 
thus leading to the speckled appearance in the sg1,2,3 hand1 mutants. Furthermore, the 
probability of inserting a stop codon is small, which could also account for why there is not a 
drastic loss of hand1 mRNA in the hand1 mutants. Despite the lack of an antibody to 
definitively test the loss of hand1, the data from TIDE provides confidence that a large 
proportion of Hand1 was non-functional, as majority of the mutations caused by the guides are 
out-of-frame deletions.  
Furthermore, embryos injected with sg1,2,3 exhibited a more severe phenotype for each assay 
than sg1 alone, presumably due to increased chance of producing a non-functional protein 
because of two targets sites within the same gene. Studies have shown that injection of two 
sgRNAs targeting the same gene in both Caenorhabditis elegans and mouse models are able 
to effectively delete regions up to 25kb long between the two target sites (Chen et al., 2014; 
Han et al., 2014). For each hand1 chromosome the two sgRNA sites are only 50-60bp apart 
from each other, therefore it is plausible that there is a larger deletion could occur in the 
embryos injected with sg1,2,3, which could account for the increased phenotype severity seen 
in sg1,2,3 injected embryos compared to sg1 injected embryos.  
4.2 Hand1 is required for proper heart morphogenesis  
Hand1 is required for heart development in mice (Firulli et al., 1998; Risebro et al., 2006; 
Srivastava et al., 1995), therefore we first sought to assess the role of Hand1 in Xenopus heart 
development. Loss of hand1 in Xenopus resulted in defective looping morphogenesis, with 
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phenotypes ranging from disrupted looping to complete loss of looping of the heart. The linear 
heart phenotype we observed is quite similar to the phenotype of tetraploid-rescue hand1 null 
mice (Riley et al., 1998). The similarities in heart phenotype provides evidence that hand1 has 
a conserved role in heart morphogenesis in Xenopus, and also provides confidence that the 
Hand1 protein is non-functional. Similarly, chimera Hand1-null mice with greater than 70% 
mutant Hand1 displayed hearts that did not loop, and those with 60-70% mutant Hand1 had a 
turned heart tube, however they were much smaller than controls and were still located in the 
midline (Riley et al., 2000). The Hand1 chimera mice with a mild looping defect is similar to 
the disrupted looping phenotype we observed in hand1 mutant Xenopus, thus these embryos 
would be expected to have a mosaic cardiac cell population in regard to functional Hand1. 
Furthermore, Hand1 chimera mice with less than 50% mutant Hand1 had morphologically 
similar hearts to those of controls (Riley et al., 2000). These results from Hand1-null chimera 
mice aligns with variance in phenotype severity in hand1 mutants due to mosaicism, as 
sufficient functional Hand1 within cardiac cells could rescue the phenotype. Furthermore, 
sg1,2,3 injected embryos showed an increase in heart phenotype severity compared to sg1 
injected embryos which aligns with the idea that more cells have non-functional Hand1 in 
sg1,2,3 injected embryos. The smaller size of the turned heart in hand1 mutant embryos 
supports the hypothesized role of Hand1 in regulating the balance of cell proliferation and 
differentiation within cardiac cells (Risebro et al., 2006).  
Interestingly, over expression of hand1 in Xenopus also led to disruptions in heart 
morphogenesis, with embryos displaying both linear phenotypes and disrupted looping 
phenotypes. However, the linear phenotype was less common in hand1 over expressing 
embryos compared to the frequency of linear hearts in hand1 mutants. Other studies showed 
that over expression of Hand1 in mice under the Hand1 reporter have abnormal looped hearts 
with an elongated outflow tract presumably due to increased cardiac cell proliferation (Risebro 
et al., 2006). Although there was not an overt increase in heart size of hand1 over expressing 
embryos, the heart was nonetheless larger in the defective looping phenotype of hand1 over 
expression compared to hand1 mutants. The lack of a stable overexpression of Hand1 
throughout development could have attributed to the difference in phenotypes between mice 
and Xenopus. As shown previously, doxycycline-induced over expression of hand1 in adult 
mice hearts resulted in hypertrophy of the heart, however when doxycycline was removed, the 
hearts were able to revert back to their normal state (Breckenridge et al., 2009). As Hand1 
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levels were not maintained at consistent high levels throughout development, a decrease from 
over expressing Hand1 levels at the time of looping may have rescued or prevented defects 
due to Hand1 over expression.  
I have further shown that the defects in heart morphogenesis are not due to alterations of 
cardiac cell fate. Expression patterns of isl1 and nkx2-5 were unaltered in both hand1 mutant 
and overexpression embryos, however quantification analysis would be required to further 
validate this. Although nkx2-5 has been shown to regulate hand1 expression (Fu et al., 1998), 
there does not appear to be any negative feedback of hand1 on nkx2-5 expression patterns in 
our Hand1 overexpression model. Interestingly, a study has shown that overexpression of 
VEGF in Xenopus resulted in defective cardiac morphogenesis, specifically 63% of embryos 
had an linear heart tube and similarly showed decreased hand1 expression in the heart (Nagao 
et al., 2007). Although this is only correlational, the loss of hand1 showcasing a similar 
phenotype supports the idea that nkx2-5 and VEGF may function to induce hand1 expression 
and loss of hand1 is ultimately what led to defects in heart morphogenesis.  
Overall, hand1 does not appear to specify cardiac cell fate, but could function to regulate the 
balance between differentiation and proliferation as shown in in vitro cardiac cell models 
(Risebro et al., 2006). Although the role of Hand1 in heart development is still not fully 
understood, our data suggests that the function of Hand1 is conserved and precise control and 
regulation of Hand1 is critical for proper development of the heart.  
4.3 Hand1 is required for formation of a complex vitelline network in Xenopus 
As I have shown, hand1 expression is tightly correlated with the location of precursor 
endothelial cells expressing etv2 throughout development, and previous studies in our lab have 
shown a correlation between hand1 expression and the developing vascular plexus (Deimling 
and Drysdale, 2011). Thus, we predicted that hand1 plays a role in the development of this 
lineage. Loss of hand1 in Xenopus resulted in a decrease in both complexity and size of the 
vitelline veins. I further showed that the decrease in vascular complexity is likely caused by a 
decrease in the initial endothelial cell population early in development. The similar expression 
pattern of hand1 and etv2 throughout development provides further evidence of the 
relationship between hand1 and etv2. As apoptosis was absent in the region of vascular plexus 
development, the reduction of endothelial cells must then be due to disruptions in either cell 
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proliferation or differentiation. Additionally, we saw no difference in the development of the 
cardinal vein in Xenopus, which we expected as hand1 is not expressed in the dorsal region of 
the embryo where the cardinal vein forms, and thus loss of hand1 had no effect on cardinal 
vein development. 
Based on in vitro studies using trophoblasts and cardiac cells, hand1 plays an important role 
in regulating the balance between cell proliferation and differentiation of cell lineages (Risebro 
et al., 2006; Scott et al., 2000). Although hand1 has contrasting roles in these cell models we 
speculate that hand1 plays a similar role in the balance of proliferation and differentiation 
within the endothelial cells. Loss of Hand1 in cardiac cells led to a corresponding decrease in 
cyclin D2 (Risebro et al., 2006), therefore, it is plausible that Hand1 functions by regulating 
proliferation through the same mechanism within the endothelial cells. Cyclin D2 is involved 
in controlling cell proliferation such that decreases in cyclin D2 levels results in the halting of 
cell proliferation allowing cells to differentiate (Ruijtenberg and Van Den Heuvel, 2016). If 
Hand1 functions to regulate the levels of cyclin D2, then the loss of hand1 and therefore cyclin 
D2 in cells would result in the early differentiation of cells and thus a smaller precursor 
population, as seen in hand1 mutants.  
Although in cardiac cells, over expression of Hand1 was associated with an increase in cyclin 
D2 and thus an increase in cell proliferation, over expression of Hand1 in Xenopus did not 
increase the population of endothelial cells or influence vasculature formation. It is plausible 
that different cell types could have different thresholds for the regulation of hand1 and thus the 
levels of Hand1 within endothelial cells might not have been high enough to induce further 
proliferation.  
Furthermore, over expression of hand1 does not lead to mis-expression of vasculature cells, 
thus Hand1 does not appear to be sufficient to drive endothelial differentiation. Similarly, loss 
of Hand1 in mice did not result in a loss of endothelial cell markers in the yolk sac, supporting 
that Hand1 does not specify the endothelial lineage (Morikawa and Cserjesi, 2004). T𝛽4 has 
been identified as a target of Hand1, however supplementation of T𝛽4 in Hand1-null mice 
only appeared to rescue vasculogenesis of the yolk sac while angiogenesis of vessels still failed 
to occur (Smart et al., 2010). This study offers insights into the role of Hand1, suggesting that 
Hand1 can both regulate vasculogenesis and angiogenesis of blood vessels, however it appears 
to do this through separate mechanisms. This could explain why a complex vasculature plexus 
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in hand1 mutants was unable to form despite still expressing endothelial precursors, although 
they were ultimately still reduced in number. Therefore, Hand1 appears to be playing a more 
complex role in vasculature development in addition to regulating the balance between cell 
proliferation and differentiation. Examining proliferation markers such as Cyclin D2 within 
the vasculature plexus of hand1 mutant embryos may provide insight into the levels of 
proliferation within the endothelial cells, to confirm the role of Hand1 in regulating 
proliferation of endothelial cells during vasculature development.  
4.4 Hand1 is dispensable for hematopoietic development in Xenopus   
As Hand1 is vital for both heart and vasculature development, we next determined if Hand1 
played a role within the development of the blood and myeloid cells. However, loss of hand1 
had no effect on the differentiation of either myeloid or blood cell lineages. Similarly, loss of 
Hand1 in the yolk sac of mice resulted in normal blood formation despite defective vasculature 
development (Morikawa and Cserjesi, 2004). This result is not surprising based on hand1 
expression patterns in Xenopus. Hand1 expression is not present in the ventral blood island 
region of the embryo at the time of blood differentiation, therefore this lineage does not appear 
to be dependent on hand1 expression, although the downregulation of Hand1 in this lineage 
appears critical for proper development. It is likely that myeloid cells also differentiate in areas 
devoid of hand1 expression. We predict that the small hole devoid of hand1 expression at the 
anterior-ventral side of the embryo at stage 20 corresponds to the region of the embryo where 
spib expressing cells originated, and thus could explain why loss of hand1 had no effect on 
their development.   
Interestingly, when hand1 is overexpressed in Xenopus there is a significant decrease in 
myeloid and blood cells, however there is no noticeable difference in the expression of the 
progenitor blood cell marker scl. This unexpected loss of these two lineages could be attributed 
to hand1 acting as a regulator of proliferation and differentiation within these lineages, as seen 
in other cell models. Overexpression of hand1 could be preventing cell differentiation, which 
could explain why we see normal expression of blood progenitors despite a decrease in the 
differentiated blood cells. Alternatively, the ectopic expression of hand1 in hematopoietic cell 
lineages that normally exhibit a downregulation of hand1 during lineage differentiation could 
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result in inappropriate binding partner formation and thus inappropriate gene regulation within 
these lineages, thus preventing proper differentiation.  
Over expression of hand1 in ectopic cells could deplete the pool of partner transcription factors 
thereby preventing transcription factors from activating genes required for lineage 
differentiation. Scl and hand1 have been shown using embryonic stem cell models to bind 
enhancer sequences of similar genes, however scl was found to bind similar enhancers with a 
greater affinity than hand1 (Org et al., 2015). They further suggest a model where 
differentiation of lineages requires binding of specific transcription factors to both silence 
genes of other lineages while promoting genes necessary for differentiation of the lineage of 
interest (Org et al., 2015). As there is no change in the expression of scl in hand1 over 
expressing Xenopus, the increased level of Hand1 could outcompete Scl for binding of genes 
required for erythrocyte differentiation resulting in the reduction of globin expression that was 
seen in Xenopus Hand1 mutants.  
This study showed that Hand1 does not normally play a role in the development of myeloid or 
blood cells, however interpretation of the result of over expression of Hand1 on these lineages 
remains unclear, although abnormal binding and gene regulation of Hand1 could be implicated 
in the reason for the decrease of hematopoietic lineages.  
4.5 Limitations and future directions  
This study has shown that hand1 is required for proper heart morphogenesis and this 
requirement is conserved throughout species. Furthermore, Hand1 is required for the formation 
of a complex vasculature plexus in the embryo through maintaining proliferation of early 
endothelial cells. Finally, we show that Hand1 is not required for the development of the 
hematopoietic lineages, but downregulation of Hand1 is important for proper differentiation of 
these lineages. Overall, Hand1 appears to have tissue dependent roles, which most likely is due 
to the different binding partners available within each lineage, as well as post-translational 
modifications that alter the affinity of Hand1 dimerization partners. Future studies are still 
needed to elucidate the targets and binding partners of Hand1 that facilitate its downstream 
effects.  
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As mentioned previously, one of the disadvantages of utilizing the CRISPR/Cas9 system in 
Xenopus is the variation in mutations within the pooled population of mutant embryos. As 
Hand1 is a small protein, it would be interesting to use two guides to completely remove the 
gene from the genome or removing the start site of the protein could reduce variations in 
phenotype by eliminating potential indels resulting in a functional protein. Although TIDE 
provides good evidence that majority of the Hand1 protein should be non-functional, reducing 
the mosaicism may reduce phenotype variability to allow for greater clarification the role of 
Hand1.  
Additionally, to further assess the development of the heart, either reconstruction of serial 
sections or confocal imaging could provide more insight into the precise defects that are 
occurring when Hand1 is altered in the embryo. Furthermore, as proper looping is necessary 
for proper heart chamber formation, studies looking at later development of the heart, and 
potential functional studies would provide better analysis as to consequences of hand1 loss in 
development of the heart. Additionally, staining for markers of proliferation within both the 
heart and the vasculature would allow for a better understanding of the role of Hand1 in 
regulating proliferation within these tissues.  
Although over expression of Hand1 provided some insight into the role of Hand1 during 
development, over expression models can cause inappropriate actions in other tissues where it 
is typically not expressed. Unwanted binding of other proteins and abnormal activation or 
repression of nontarget genes make interpretation of over expression difficult. Over expressing 
Hand1 in tissue specific regions by injecting synthetic mRNA into specific cells at later stages 
could reduce abnormal binding partner formation and gene regulation by Hand1 in other 
lineages where Hand1 is not normally expressed.  
Determining the targets of Hand1 will provide the insight into the mechanisms by Hand1 exerts 
its actions. Performing ChIP sequencing using a tagged Hand1 in Xenopus, will allow for the 
identification of Hand1 targets. By combining the results of ChIP sequencing targets with RNA 
sequencing of hand1 mutant embryos, we can determine which target genes are mis-regulated 
when hand1 is lost, and thus provide us with a more concise list of potential targets of hand1. 
Preliminary studies where I have over expressed Hand1-MT in Xenopus show a similar 
phenotype to that of untagged Hand1 over expressing embryos, thus showing the addition of a 
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Myc tag does not appear to effect Hand1 function and thus ChIP sequencing analysis using 
Hand1-MT would provide a robust list of potential Hand1 targets.  
Although we are still far from a complete understanding of the molecular mechanisms by 
which Hand1 regulates development, this study confirmed the role of Hand1 within the heart 
is conserved and provided insight into a new function of Hand1 within the embryonic 
vasculature. Based on the decrease of endothelial cells in hand1 mutants, we speculate that 
Hand1 is required to keep cells in a proliferative state throughout development, ensuring proper 
development of lineages. Elucidating the targets and binding partners of Hand1 will provide 
better insight into how Hand1 functions throughout development and in disease states. As 
dysregulation of Hand1 function is correlated with development of congenital heart defects, 
understanding the molecular basis of Hand1 will be vital for beginning to prevent and treat 
these conditions.   
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